Stress- and Glucocorticoid-Induced Priming of Neuroinflammatory Responses: Potential Mechanisms of Stress-Induced Vulnerability to Drugs of Abuse
Open accessAbstract
Stress and stress-induced glucocorticoids (GCs) sensitize drug abuse behavior as well as the neuroinflamatory response to a subsequent pro-inflammatory challenge. Stress also predisposes or sensitizes individuals to develop substance abuse. There is an emerging evidence that glia and glia-derived neuroinflammatory mediators play key roles in the development of drug abuse. Drugs of abuse such as opioids, psychostimulants, and alcohol induce neuroinflammatory mediators such as pro-inflammatory cytokines (e.g. interleukin (IL)-1β), which modulate drug reward, dependence, and tolerance as well as analgesic properties. Drugs of abuse may directly activate microglial and astroglial cells via ligation of Toll-like receptors (TLRs), which mediate the innate immune response to pathogens as well as xenobiotic agents (e.g. drugs of abuse). The present review focuses on understanding the immunologic mechanism(s) whereby stress primes or sensitizes the neuroinflammatory response to drugs of abuse and explores whether stress- and GC-induced sensitization of neuroimmune processes predisposes individuals to drug abuse liability and the role of neuroinflammatory mediators in the development of drug addiction.
AI snapshot
Written from the paper’s full text.
TL;DR
This review proposes that stress and stress-induced glucocorticoids prime/sensitize CNS innate immunity, especially microglia, so that subsequent drugs of abuse acting as danger signals via TLRs produce exaggerated neuroinflammatory responses that facilitate drug reward, dependence, tolerance, and relapse. It synthesizes evidence that opioids, psychostimulants, and alcohol activate glia/neuroinflammatory mediators, but notes the key stress/GC-to-drug neuroinflammation link has not been directly tested.
Key findings
- Stress produces acute CNS pro-inflammatory cytokine increases (elevated immediately after ~2 h stress, persisting 4–6 h) and delayed priming: prior stress potentiates LPS-induced neuroinflammation 1–4 days later; 24 h post-stress microglia show upregulated MHCII and downregulated CD200, and isolated hippocampal microglia respond more strongly to LPS in vitro.
- GC timing matters: a single GC dose 2 h or 24 h before LPS potentiated neuroinflammation, while 1 h after LPS reduced it; GCs increased central TLR2 and potentiated LPS induction of TLR4 24 h post-GC; in vivo GC treatment potentiated IL-1β/TNFα response to LPS ex vivo dose-dependently.
- Drugs of abuse activate glia and neuroinflammatory mediators: morphine/opioids induce IL-1β, IL-6, TNFα, and TLR4; morphine and other clinically relevant opioids (oxycodone, methadone) act as TLR4 agonists in TLR4-transfected HEK-293 cells; TLR4 knockout mice show enhanced morphine analgesia and attenuated tolerance; morphine-3-glucuronide (M3G) activates TLR4 signaling and IL-1β, blocked by LPS-RS, (+)-naloxone, minocycline, and IL-1 receptor antagonist.
- Methamphetamine activates microglia (human users show activation at least 2 years after abstinence), induces PICs/chemokines/oxidative stress, and prior Meth potentiates LPS-induced cytokines and microglial activation; alcohol activates microglia/astrocytes and increases IL-1/NF-κB, with TLR4 deficiency or knockdown blocking alcohol-induced neuroinflammatory responses.
Methods
- Narrative review; no primary experimental data reported.
- Synthesizes published animal, in vitro, human postmortem/imaging, and pharmacological studies on stress, glucocorticoids, microglia/TLRs, and drugs of abuse.
- Main analysis is conceptual integration of cited findings into a model of stress/GC-induced neuroinflammatory priming and drug abuse vulnerability.
Limitations
- Authors state the mechanism(s) of stress-induced inflammatory priming is almost entirely unknown, and stress- and GC-induced sensitization of the neuroinflammatory response to drugs of abuse has not been investigated.
- Authors note evidence that methamphetamine acts through PRRs/TLRs is lacking; the duration of alcohol exposure required is unknown; and the mechanism by which alcohol and other drugs lead to TLR signaling awaits clarification.
- Evident from the text: as a review, it presents a speculative framework without direct experimental test of the central stress/GC-to-drug neuroinflammation hypothesis.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 66 cited sources checked · 0 supported · 0 flagged
- Premisecitation
Chronic morphine activated glia in both the spinal cord and brain.
“Song and Zhao found that chronic morphine activated glia in both the spinal cord and brain (Song and Zhao, 2001).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Song and Zhao, 2001 source
Not checked in the free run.
- Interpretationown data
Stress and stress-induced GCs sensitize CNS innate immune responses to pro-inflammatory stimuli.
“As a summary, these experiments show that stress and stress-induced GCs sensitize CNS innate immune responses to pro-inflammatory stimuli.”
Quote in the paperSubstantial claim - Premiseown data
GCs given either 2 h or 24 h before LPS potentiated the neuroinflammatory response to LPS.
“However, GCs given either 2 h or 24 h before LPS potentiated the neuroinflammatory response to LPS.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Frank et al., 2010 source
Not checked in the free run.
- Premisenone given
Drugs of abuse such as opioids, psychostimulants, and alcohol induce neuroinflammatory mediators such as pro-inflammatory cytokines (e.g. interleukin (IL)-1β).
“Drugs of abuse such as opioids, psychostimulants, and alcohol induce neuroinflammatory mediators such as pro-inflammatory cytokines (e.g. interleukin (IL)-1β), which modulate drug reward, dependence, and tolerance as well as analgesic properties.”
Quote in the paperSubstantial claim - Interpretationown data
Exposure to an acute stressor shifts the neuroimmune microenvironment toward a microglial activation state that predisposes the CNS to a heightened pro-inflammatory response if exposed to a subsequent pro-inflammatory challenge.
“Taken together, the studies conducted in our laboratory demonstrate that exposure to an acute stressor shifts the neuroimmune microenvironment toward a microglial activation state that predisposes the CNS to a heightened pro-inflammatory response if exposed to a subsequent pro-inflammatory challenge.”
Quote in the paperSubstantial claim
- Premisenone given
Pro-inflammatory cytokines modulate drug reward, dependence, and tolerance as well as analgesic properties.
“Drugs of abuse such as opioids, psychostimulants, and alcohol induce neuroinflammatory mediators such as pro-inflammatory cytokines (e.g. interleukin (IL)-1β), which modulate drug reward, dependence, and tolerance as well as analgesic properties.”
Quote in the paperSubstantial claim - Premisecitation
Prior chronic stress potentiated the LPS-induced hippocampal and prefrontal cortex increase in IL-1β, TNFα, and iNOS mRNA, as well as NF-κB activity.
“Prior chronic stress potentiated the LPS-induced hippocampal and prefrontal cortex increase in IL-1β, TNFα, and iNOS mRNA, as well as NF-κB activity.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Munhoz et al., 2006 source
Not checked in the free run.
- Premisecitation
Activated glia and glia-derived neuroinflammatory mediators play an important role in drug reward, dependence, tolerance and analgesic properties.
“An emerging body of evidence suggests that activated glia and glia-derived neuroinflammatory mediators play an important role in drug reward, dependence, tolerance and analgesic properties (Hutchinson et al., 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Hutchinson et al., 2007 source
Not checked in the free run.
- Premisecitation
Stressors can induce a rapid, short duration increase in inflammatory mediators in the brain.
“The first is a rapid, short duration (several hours) increase in inflammatory mediators (Nguyen et al., 1998).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Nguyen et al., 1998 source
Not checked in the free run.
- Premiseown data
GCs given 1 h after LPS reduced the neuroinflammatory response.
“GCs given 1 h after LPS reduced the neuroinflammatory response.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Frank et al., 2010 source
Not checked in the free run.
- Premisecitation
Exposure to stressors and pro-inflammatory agents induces a similar profile of pro-inflammatory cytokine signatures in the CNS.
“Exposure to stressors and pro-inflammatory agents induces a similar profile of pro-inflammatory “cytokine signatures” in the CNS (Maier, 2003).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Maier, 2003 source
Not checked in the free run.
- Premisecitation
Glia and glia-derived neuroinflammatory mediators play key roles in the development of drug abuse.
“There is an emerging evidence that glia and glia-derived neuroinflammatory mediators play key roles in the development of drug abuse.”
- Also stated in: § 4. Drugs of abuse and neuroinflammation · hedged
“An emerging body of evidence suggests that activated glia and glia-derived neuroinflammatory mediators play an important role in drug reward, dependence, tolerance and analgesic properties (Hutchinson et al., 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Hutchinson et al., 2007 source
Not checked in the free run.
- Also stated in: § 4. Drugs of abuse and neuroinflammation · hedged
- Interpretationreasoning
Stress- and GC-induced sensitization of neuroinflammatory responses to drugs of abuse may be involved in driving the neuroadaptations underlying drug abuse liability.
“In light of evidence that drugs of abuse exhibit pro-inflammatory properties and activate TLRs (see below), stress- and GC-induced sensitization of neuroinflammatory responses to drugs of abuse may be involved in driving the neuroadaptations underlying drug abuse liability.”
Quote in the paperSubstantial claim- Rests on an assumption: Stress and stress-induced glucocorticoids sensitize drug abuse behavior.
- Interpretationnone given
Stress and stress-induced glucocorticoids sensitize the neuroinflammatory response to a subsequent pro-inflammatory challenge.
“Stress and stress-induced glucocorticoids (GCs) sensitize drug abuse behavior as well as the neuroinflamatory response to a subsequent pro-inflammatory challenge.”
- Also stated in: § 1. Introduction · plain
“Stress and stress-induced glucocorticoids (GCs) sensitize drug abuse behavior as well as the neuroinflammatory response to subsequent pro-inflammatory challenges.”
Quote in the paperSubstantial claim - Also stated in: § 1. Introduction · plain
- Interpretationreasoning
Stress-induced sensitization of neuroinflammatory processes may be a key mechanism by which stress predisposes individuals to developing drug abuse.
“We will present converging evidence that stress-induced sensitization of neuroinflammatory processes may be a key mechanism(s) by which stress predisposes individuals to developing drug abuse.”
Quote in the paperSubstantial claim- Rests on an assumption: Stress predisposes or sensitizes individuals to develop substance abuse.
- Premisereasoning
Drugs of abuse may directly activate microglial and astroglial cells via ligation of Toll-like receptors (TLRs).
“Drugs of abuse may directly activate microglial and astroglial cells via ligation of Toll-like receptors (TLRs), which mediate the innate immune response to pathogens as well as xenobiotic agents (e.g. drugs of abuse).”
Quote in the paperNot a substantial claim - Premisecitation
This potentiation was GC mediated (blocked by RU486).
“Importantly, this potentiation was shown to be GC mediated (i.e. blocked by RU486).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Munhoz et al., 2006 source
Not checked in the free run.
- Premiseown data
In vivo GC treatment potentiated the PIC (IL-1β, TNFα) response to LPS ex vivo in a dose dependent manner.
“In vivo GC treatment potentiated the PIC (IL-1β, TNFα) response to LPS ex vivo in a dose dependent manner.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Frank et al., 2010 source
Not checked in the free run.
- Interpretationown data
GCs sensitize microglia to a pro-inflammatory challenge.
“This experiment provided compelling evidence that GCs sensitize microglia to a pro-inflammatory challenge.”
Quote in the paperSubstantial claim - Premisecitation
GCs are sometimes either without effect or strongly pro-inflammatory.
“However, this issue has recently been re-examined in a review by Sorrells and Sapolsky (2007), with the authors concluding that GCs are indeed sometimes either without effect or strongly pro-inflammatory.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Sorrells and Sapolsky (2007)
Not checked in the free run.
- Premisecitation
GCs are not involved in the initiation of the immediate short-term inflammatory response to stress.
“Importantly, it is quite clear that GCs are not involved in the initiation of this immediate short-term inflammatory response to stress as adrenalectomy potentiates the response (Nguyen et al., 1998) and GC injection before the stressor inhibits it (Nguyen et al., 2000).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Stressors can induce a slower developing, longer lasting sensitization (priming) of neuroinflammatory responses to subsequently occurring infectious/pathogenic stimuli or stressors.
“The second is a slower developing, longer lasting (days) sensitization (or “priming”) of neuroinflammatory responses to subsequently occurring infectious/pathogenic stimuli or stressors (i.e. delayed challenge) (Johnson et al., 2003).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Johnson et al., 2003 source
Not checked in the free run.
- Premisecitation
Repeated methamphetamine treatment increases TNFα throughout the brain.
“repeated Meth treatment increased TNFα throughout the brain (Nakajima et al., 2004)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Nakajima et al., 2004 source
Not checked in the free run.
- Premisecitation
Effects of Meth were ameliorated in IL-6 KO animals.
“Here, the effects of Meth were found to be ameliorated in IL-6 KO animals.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ladenheim et al., 2000 source
Not checked in the free run.
- Premisecitation
In rhesus monkeys, chronic methamphetamine increases striatal expression of TNF and NF-κB.
“and striatal expression of TNF and NF-κB (Lai et al., 2009)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lai et al., 2009 source
Not checked in the free run.
- Premisecitation
Acute methamphetamine potentiates chemokine expression to the HIV Tat protein.
“as well as the chemokine expression to the HIV Tat protein (Theodore et al., 2006)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Theodore et al., 2006 source
Not checked in the free run.
- Premisecitation
Methamphetamine-induced neurotoxicity is attenuated in IL-6 knockout mice.
“Here, the effects of Meth were found to be ameliorated in IL-6 KO animals.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ladenheim et al., 2000 source
Not checked in the free run.
- Premisecitation
Inhibition of pro-inflammatory cytokines reversed the development of morphine tolerance and withdrawal-induced hyperalgesia.
“Inhibition of pro-inflammatory cytokines reversed the development of morphine tolerance and withdrawal-induced hyperalgesia.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Raghavendra et al., 2004 source
Not checked in the free run.
- Premisecitation
Acute methamphetamine-induced increases in expression of TNF, TNFr1, TNFr2, IL-1α, and IL-6 are blocked by pretreatment with minocycline.
“acute Meth-induced increases in the expression of TNF, TNFr1, TNFr2, IL-1α, and IL-6 were blocked by pretreatment with the microglia inhibitor minocycline (Sriram et al., 2006)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Sriram et al., 2006 source
Not checked in the free run.
- Premisecitation
Morphine and other clinically relevant opioids (oxycodone and methadone) function as TLR4 agonists.
“Importantly, we have also shown that morphine and other clinically relevant opioids (oxycodone and methadone) function as TLR4 agonists using TLR4 transfected human embryonic kidney (HEK-293) cells (Hutchinson et al., 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Hutchinson et al., 2007 source
Not checked in the free run.
- Premisecitation
IL-6 is implicated in Meth-induced astrogliosis, oxidative stress, and neurotoxicity in several brain regions including the striatum, frontal cortex, and hippocampus.
“Several groups have extended this finding to show that Meth induces PICs across several brain regions including brain reward pathways, and Ladenheim et al. implicated IL-6 in Meth-induced astrogliosis, oxidative stress, and neurotoxicity in several brain regions including the striatum, frontal cortex, and hippocampus (Ladenheim et al., 2000).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ladenheim et al., 2000 source
Not checked in the free run.
- Premisecitation
Microglial activation was elevated in several brain regions including the striatum in long-term Meth users.
“Of note, a study in humans demonstrated that microglial activation was elevated in several brain regions including the striatum in long-term Meth users (Sekine et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Sekine et al., 2008 source
Not checked in the free run.
- Premisecitation
Meth induces PICs across several brain regions including brain reward pathways.
“Several groups have extended this finding to show that Meth induces PICs across several brain regions including brain reward pathways, and Ladenheim et al. implicated IL-6 in Meth-induced astrogliosis, oxidative stress, and neurotoxicity in several brain regions including the striatum, frontal cortex, and hippocampus (Ladenheim et al., 2000).”
Quote in the paperNot a substantial claim - Interpretationreasoning
If IL-1β down-regulation of GLT-1 occurred in the VTA or NAcc, the dopaminergic neurotransmission that is critical to drug reward would be potentiated.
“If this were to occur in the ventral tegmental area (VTA) or nucleus accumbens (NAcc), the dopaminergic neurotransmission that is critical to drug reward would be potentiated.”
Quote in the paperSubstantial claim - Premisecitation
Microglia activation was observed at least 2 years after Meth abstinence.
“Strikingly, microglia activation was observed at least 2 years after Meth abstinence.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Sekine et al., 2008 source
Not checked in the free run.
- Premisecitation
Meth induces an array of neuroinflammatory effects including PIC, chemokines, and oxidative stress.
“Further, Meth induces an array of neuroinflammatory effects including PIC, chemokines, and oxidative stress (Cadet and Krasnova, 2009; Krasnova and Cadet, 2009).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Cadet and Krasnova, 2009
Not checked in the free run.
- cites Krasnova and Cadet, 2009
Not checked in the free run.
- Premisecitation
Methamphetamine-induced behavioral hyperactivity and sensitization is potentiated in TNFα knockout animals.
“Meth-induced behavioral hyperactivity and sensitization was potentiated in TNFα KO animals.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Nakajima et al., 2004 source
Not checked in the free run.
- Premisecitation
Acute methamphetamine potentiates the cytokine response to HIV TAT.
“potentiated cytokine response to HIV TAT (Flora et al., 2003)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Flora et al., 2003 source
Not checked in the free run.
- Premisecitation
Acute methamphetamine increases TNF expression in the striatum and frontal cortex.
“Acute Meth increased striatal and frontal cortex expression of TNF (Flora et al., 2002).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Flora et al., 2002 source
Not checked in the free run.
- Premisecitation
Indomethacin pretreatment can prevent the neuroinflammatory effects of methamphetamine.
“indomethacin (a non-steroidal anti-inflammatory) pretreatment can prevent the neuroinflammatory effects of Meth (Goncalves et al., 2010)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Goncalves et al., 2010 source
Not checked in the free run.
- Premisecitation
In rhesus monkeys, chronic methamphetamine increases interferon α/β in the frontal lobe.
“In rhesus monkeys, chronic Meth increased interferon α/β in frontal lobe (Coutinho et al., 2008)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Coutinho et al., 2008 source
Not checked in the free run.
- Premisecitation
Methamphetamine induces pro-inflammatory cytokines in the central nervous system.
“Additional studies have demonstrated that Meth indeed induces PICs in CNS.”
Quote in the paperSubstantial claim - Premisecitation
Prior methamphetamine administration potentiates microglial activation induced by LPS.
“prior Meth also potentiated the microglial activation induced by LPS (Buchanan et al., 2010)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Buchanan et al., 2010 source
Not checked in the free run.
- Premisecitation
Acute methamphetamine increases TNFα and IL-1β in the striatum.
“Likewise, acute Meth increased TNFα and IL-1β in striatum”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Flora et al., 2003 source
Not checked in the free run.
- Premisecitation
Prior methamphetamine administration potentiates the pro-inflammatory cytokine response to LPS across several brain regions including striatum, hypothalamus, hippocampus, cortex, and cerebellum.
“prior Meth administration potentiated the pro-inflammatory cytokine response to LPS across several brain regions including striatum, hypothalamus, hippocampus, cortex, and cerebellum”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Buchanan et al., 2010 source
Not checked in the free run.
- Premisecitation
In vitro, brief exposure to alcohol at physiological concentrations (50 nM) induces inflammatory processes in astrocytes.
“In vitro, even a brief exposure to alcohol at physiological concentrations (50 nM) induces inflammatory processes in astrocytes (Blanco et al., 2005)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Blanco et al., 2005 source
Not checked in the free run.
- Premisecitation
Stress and glucocorticoids activate brain reward pathways, such as dopamine signaling in the nucleus accumbens, in a manner similar to drugs of abuse.
“stress and GCs activate brain reward pathways, such as dopamine signaling in the nucleus accumbens, in a manner similar to drugs of abuse (Marinelli and Piazza, 2002).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Marinelli and Piazza, 2002
Not checked in the free run.
- Premisecitation
Chronic alcohol exposure in vivo activates microglia and astrocytes.
“Chronic exposure to alcohol in vivo activates microglia and astrocytes (Fernandez-Lizarbe et al., 2009)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Fernandez-Lizarbe et al., 2009 source
Not checked in the free run.
- Premisecitation
Chronic alcohol exposure increases brain levels of inflammatory mediators such as IL-1.
“increases brain levels of inflammatory mediators such as IL-1 (Qin et al., 2008)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Qin et al., 2008 source
Not checked in the free run.
- Interpretationreasoning
The neuroinflammatory effects of methamphetamine may be secondary to the neurotoxic effects of methamphetamine.
“Therefore, the above evidence suggests that the neuroinflammatory effects of Meth may be secondary to the neurotoxic effects of Meth.”
Quote in the paperSubstantial claim- Rests on an assumption: Evidence of methamphetamine acting through pattern recognition receptors such as TLRs is lacking.
- Premisecitation
Chronic alcohol exposure activates inflammatory transcription factors such as NF-κB.
“activates inflammatory transcription factors such as NF-κB (Valles et al., 2004)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Valles et al., 2004 source
Not checked in the free run.
- Premisecitation
Adrenalectomy blocks stress-induced potentiation of drug reward.
“adrenalectomy blocks stress-induced potentiation of drug reward (Der-Avakian et al., 2005)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Der-Avakian et al., 2005 source
Not checked in the free run.
- Interpretationcitation
A small but consistent literature suggests that alcohol acts at TLR4.
“a small but consistent literature suggests action at TLR4.”
Quote in the paperNot a substantial claim - Interpretationcitation
The TNFα response to methamphetamine plays a neuroprotective role.
“This study suggests that the TNFα response to Meth plays a neuroprotective role.”
Quote in the paperSubstantial claim - Premisecitation
In vitro, brief exposure to alcohol at physiological concentrations (50 nM) induces inflammatory processes in microglia.
“In vitro, even a brief exposure to alcohol at physiological concentrations (50 nM) induces inflammatory processes in astrocytes (Blanco et al., 2005) and microglia (Fernandez-Lizarbe et al., 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Fernandez-Lizarbe et al., 2009 source
Not checked in the free run.
- Premisecitation
Methamphetamine is neurotoxic, depending on dose and time course of administration.
“A considerable literature has demonstrated that Meth is neurotoxic, depending on dose and time course of administration (Krasnova and Cadet, 2009).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Krasnova and Cadet, 2009
Not checked in the free run.
- Premisecitation
Chronic unpredictable stress potentiates the hyperthermic response to methamphetamine.
“A regimen of chronic unpredictable stress potentiated the hyperthermic response to Meth (Matuszewich and Yamamoto, 2004).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Matuszewich and Yamamoto, 2004
Not checked in the free run.
- Interpretationreasoning
In methamphetamine exposure, neurotoxicity may result in the release of inflammatory factors (e.g., HMGB1) resulting in activation of microglia and release of pro-inflammatory mediators.
“In the case of Meth exposure, neurotoxicity may result in the release of inflammatory factors (i.e. HMGB1 etc.) resulting in the activation of microglia and release of pro-inflammatory mediators.”
Quote in the paperSubstantial claim - Premisecitation
Stress and glucocorticoids sensitize the rewarding properties of morphine.
“stress as well as GCs sensitizes the rewarding properties of morphine”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Der-Avakian et al., 2005 source
Not checked in the free run.
- Premisecitation
As few as three daily doses of alcohol (4 g/kg i.g. in mice) induce microglial activation in the cortex.
“as few as three daily doses of alcohol (4 g/kg i.g. in mice, Fernandez-Lizarbe et al., 2009) have been reported to induce microglial activation in cortex.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Fernandez-Lizarbe et al., 2009 source
Not checked in the free run.
- Interpretationreasoning
Stressors, possibly mediated by the glucocorticoid rise they produce, sensitize microglial pro-inflammatory responses to subsequent immune challenge, likely via up-regulation of TLRs.
“stressors, possibly mediated by the GC rise that they produce, sensitize microglial pro-inflammatory responses to subsequent immune challenge, likely via up-regulation of TLRs”
Quote in the paperSubstantial claim - Premisecitation
Treatment with Ibudilast attenuates stress-induced reinstatement of extinguished methamphetamine-maintained responding.
“attenuated stress-induced reinstatement of extinguished Meth-maintained responding (Beardsley et al., 2010)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Beardsley et al., 2010 source
Not checked in the free run.
- Premisecitation
In microglia taken from TLR4 deficient mice, alcohol-induced microglial activation markers, NF-κB activation, and PIC production are absent.
“Fernandez-Lizarbe et al. (2009) found all of these to be absent in microglia taken from TLR4 deficient mice.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Fernandez-Lizarbe et al., 2009 source
Not checked in the free run.
- Premisecitation
Drugs of abuse activate the hypothalamo-pituitary-adrenal (HPA) axis.
“drugs of abuse activate the hypothalamo-pituitary–adrenal (HPA) axis (Armario, 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Armario, 2010 source
Not checked in the free run.
- Premisecitation
Metyrapone treatment during chronic stress blocks the stress-induced potentiation of the hyperthermic response to methamphetamine.
“which was blocked by treating animals with the glucocorticoid synthesis inhibitor, metyrapone, during chronic stress exposure (Tata and Yamamoto, 2008)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Tata and Yamamoto, 2008
Not checked in the free run.
- Premisecitation
TLR4 knockout and knockdown with siRNAs block alcohol-induced neuroinflammatory responses in vivo.
“TLR4 knockout (Fernandez-Lizarbe et al., 2009) and knockdown with siRNAs (Alfonso-Loeches et al., 2010) also blocked alcohol-induced neuroinflammatory responses in vivo.”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Prior chronic stress potentiates the hyperthermic response to methamphetamine.
“Prior chronic stress was also found to potentiate the hyperthermic response to Meth”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Tata and Yamamoto, 2008
Not checked in the free run.
- Interpretationreasoning
The neuroinflammatory response to drugs of abuse potentiates well-known drug pathways such as the VTA-NAcc dopamine system.
“This neuroinflammatory response then potentiates well-known drug pathways such as the VTA–NAcc dopamine system.”
Quote in the paperSubstantial claim - Interpretationreasoning
Stressors potentiate drug-related behaviors, in part, because drugs of abuse act at TLRs on microglia that have been up-regulated by prior stressor exposure, thereby leading to an exaggerated neuroinflammatory response to the drugs.
“stressors potentiate drug-related behaviors, in part, because the drugs of abuse act at TLRs on microglia that have been up-regulated by prior stressor exposure, thereby leading to an exaggerated neuroinflammatory response to the drugs.”
Quote in the paperSubstantial claim - Interpretationreasoning
Drugs of abuse, viewed as xenobiotic agents, function as pro-inflammatory stimuli much like a microbial pathogen, which the organism "sees" as both foreign and dangerous and thereby mounts a central immune response.
“drugs of abuse, viewed as xenobiotic agents, function as pro-inflammatory stimuli much like a microbial pathogen, which the organism “sees” as both foreign and dangerous and thereby mounts a central immune response.”
Quote in the paperSubstantial claim
- May combine two claims. 17
- Classified as probably not a substantial claim. 1
May combine two claims.
InterpretationcitationStressors induce inflammation despite elevations in GCs, not because of the elevations.
“That is, stressors induce inflammation despite elevations in GCs, not because of the elevations.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataDelayed stress-induced activation of the neuroimmune microenvironment does not include tonic induction of increased levels of pro-inflammatory cytokines; increased pro-inflammatory responses are not observed until a subsequent challenge occurs.
“However, delayed stress-induced activation of the neuroimmune microenvironment does not include tonic induction of increased levels of pro-inflammatory cytokines; rather, increased pro-inflammatory responses are not observed until a subsequent challenge occurs.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationPro-inflammatory effects of GCs have been most often observed when neuroinflammatory responses, rather than peripheral innate immune responses, have been examined, with dose, duration of GC increase, and timing being important variables.
“Sorrels and Sapolsky concluded that pro-inflammatory effects have been most often observed when neuroinflammatory responses, rather than peripheral innate immune responses have been examined, with dose, duration of GC increase, and timing being important variables.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Sorrells and Sapolsky (2007)
Not checked in the free run.
May combine two claims.
Premiseown dataExogenous GCs increased central expression of TLR2 and potentiated the LPS induction of TLR4 24 h post-GC administration.
“Importantly, exogenous GCs increased central expression of TLR2 and potentiated the LPS induction of TLR4 24 h post-GC administration.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Frank et al., 2010 source
Not checked in the free run.
May combine two claims.
PremisecitationBlockade of the GC receptor with RU486 abolished stress-induced microglia activation, and exogenous GC administration mimicked the effect of stress on microglia proliferation.
“Further, blockade of the GC receptor with the GC receptor antagonist RU486 abolished stress-induced microglia activation, and exogenous GC administration mimicked the effect of stress on microglia proliferation.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Nair and Bonneau, 2006
Not checked in the free run.
May combine two claims.
InterpretationreasoningUpon exposure to drugs of abuse, a neuroinflammatory cascade ensues, which facilitates drug reward, dependence, and tolerance, as well as modulation of drug-induced analgesia.
“Therefore, upon exposure to drugs of abuse, a neuroinflammatory cascade ensues, which facilitates drug reward, dependence, and tolerance, as well as modulation of drug-induced analgesia.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataStress-induced brain cytokine increases are transient, but the neuroimmune microenvironment displays a gradual increase in glial activation markers post-stress, which may underlie the sensitized neuroinflammatory response to a subsequent pro-inflammatory challenge.
“While stress-induced brain cytokine increases are transient and short-lived, the neuroimmune microenvironment displays a gradual increase in glial activation markers post-stress, which may underlie the sensitized neuroinflammatory response that occurs to a subsequent pro-inflammatory challenge, such as drugs of abuse.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Frank et al., 2007 source
Not checked in the free run.
May combine two claims.
PremisecitationChronic morphine activated glia and up-regulated the expression of pro-inflammatory cytokines (IL-1β, IL-6, and TNFα).
“Similarly, chronic morphine activated glia and up-regulated the expression of pro-inflammatory cytokines (i.e. IL-1β, IL-6, and TNFα) (Raghavendra et al., 2004).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Raghavendra et al., 2004 source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Premisenone givenDrugs of abuse may function, in part, as pro-inflammatory stimuli or danger signals to induce neuroinflammatory responses.
“We will develop the thesis that drugs of abuse (e.g. methamphetamine, morphine and alcohol) may function, in part, as pro-inflammatory stimuli or danger signals to induce neuroinflammatory responses.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationTLR4 knock out mice exhibit enhanced morphine analgesia and attenuated development of morphine tolerance.
“Importantly, in line with such observations, we demonstrated that TLR4 knock out mice exhibit enhanced morphine analgesia and attenuated development of morphine tolerance (Hutchinson et al., 2010b).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Hutchinson et al., 2010b
Not checked in the free run.
May combine two claims.
PremisecitationIL-1β can down-regulate the glutamate transporter GLT-1, thereby increasing glutamatergic neurotransmission.
“Although there are a variety of ways in which glial activation and the consequent release of inflammatory mediators could play a role in drug-related processes, it may be especially important that IL-1β can down-regulate the glutamate transporter GLT-1 (Tilleux and Hermans, 2007), thereby increasing glutamatergic neurotransmission.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Tilleux and Hermans, 2007 source
Not checked in the free run.
May combine two claims.
PremisecitationAcute Meth treatment increased hypothalamic IL-1β, which reflects the hyperthermic effects of Meth.
“Two initial reports demonstrated that acute Meth treatment increased hypothalamic IL-1β (Yamaguchi et al., 1991a,b), which reflects the hyperthermic effects of Meth (Krasnova and Cadet, 2009).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Yamaguchi et al., 1991a,b
Not checked in the free run.
- cites Krasnova and Cadet, 2009
Not checked in the free run.
May combine two claims.
Interpretationnone givenA number of drugs of abuse activate microglia, likely via action at TLRs, with this aspect of drug action being involved in the mediation of several drug-related behaviors.
“a number of drugs of abuse activate microglia, likely via action at TLRs, with this aspect of drug action being involved in the mediation of several drug-related behaviors”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationAlcohol rapidly activates microglia in vitro, up-regulating microglial activation markers and leading to NF-κB activation and production of PICs.
“alcohol rapidly activates microglia in vitro, up-regulating microglial activation markers and leading to NF-κB activation and the production of PICs.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationMicroglial activation, astrogliosis, and increased expression of PICs are observed in postmortem examination of alcoholic brains.
“microglial activation, astrogliosis, and increased expression of PICs have been observed in postmortem examination of alcoholic brains (He and Crews, 2008)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites He and Crews, 2008
Not checked in the free run.
May combine two claims.
PremisecitationPretreatment with exogenous TNFα reduces methamphetamine-induced locomotor activity, the rewarding effects of methamphetamine, and several indicators of neurotoxicity.
“pretreatment with exogenous TNFα reduced Meth-induced locomotor activity, the rewarding effects of Meth, and several indicators of neurotoxicity.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Nakajima et al., 2004 source
Not checked in the free run.
May combine two claims.
PremisecitationStress and glucocorticoids facilitate and sensitize the behavioral response to drugs of abuse, including potentiation of drug reward, locomotor activity, self-administration, and relapse.
“Stress and GCs facilitate and sensitize the behavioral response to drugs of abuse including potentiation of drug reward, locomotor activity, self-administration, and relapse (de Jong and de Kloet, 2004; Piazza and Le Moal, 1997).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites de Jong and de Kloet, 2004
Not checked in the free run.
- cites Piazza and Le Moal, 1997
Not checked in the free run.
May combine two claims.
InterpretationreasoningStressors potentiate a variety of drug-related behaviors, with glucocorticoids playing a role.
“stressors potentiate a variety of drug-related behaviors, with GCs playing a role”
Quote in the paperSubstantial claim
The paper relies on this without support.
Stress and stress-induced glucocorticoids sensitize drug abuse behavior.
“Stress and stress-induced glucocorticoids (GCs) sensitize drug abuse behavior as well as the neuroinflamatory response to a subsequent pro-inflammatory challenge.”
The paper relies on this without support.
Stress predisposes or sensitizes individuals to develop substance abuse.
“Stress also predisposes or sensitizes individuals to develop substance abuse.”
The paper relies on this without support.
Evidence of methamphetamine acting through pattern recognition receptors such as TLRs is lacking.
“It should be noted that evidence of Meth acting through PRRs such as TLRs is lacking.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
These substances may directly activate microglial and astroglial cells via Toll-like receptors, contributing to neuroinflammation and the addictive process.
“These substances may directly activate microglial and astroglial cells via Toll-like receptors (TLRs), contributing to neuroinflammation and the addictive process.”
From Comprehensive review of chronic stress pathways and the efficacy of behavioral stress reduction programs (BSRPs) in managing diseases. (2024) · cites this paper as [87]
Drugs of abuse, such as opioids, psychostimulants, and alcohol, can induce neuroinflammatory mediators like IL-1β, which modulate drug reward, dependence, and tolerance.
“Drugs of abuse, such as opioids, psychostimulants, and alcohol, can induce neuroinflammatory mediators like interleukin-1β (IL-1β), which modulate the drug reward, dependence, and tolerance.”
From Comprehensive review of chronic stress pathways and the efficacy of behavioral stress reduction programs (BSRPs) in managing diseases. (2024) · cites this paper as [87]
Stress is a significant risk factor for the initiation and maintenance of cannabis use.
“Stress is also a significant risk factor for the initiation and maintenance of cannabis use [86,87].”
From Comprehensive review of chronic stress pathways and the efficacy of behavioral stress reduction programs (BSRPs) in managing diseases. (2024) · cites this paper as [87]
Cites
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304 · cited 1× · see citing works
“Interestingly, TLR signaling, in particular TLR2 and TLR4, has been co-opted by endogenous signaling molecules which are thought to alert microglia to a variety of internal conditions such as cellular stress, damage or death (Kawai and Akira, 2010).”
BackgroundExploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · see citing works
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394 · cited 2× · see citing works
“…of the innate immune system recognize microbial products via a relatively small number (roughly 30) of germ line-encoded receptors that recognize general molecular patterns that characterize different classes of pathogens (Pathogen Associated Molecular Patterns, PAMPs; Janeway and Medzhitov, 2002).”
BackgroundFrom inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395 · cited 1× · see citing works
“This relationship between major depression and alcohol abuse is of particular relevance in the context of the present review given that stress (Anisman, 2009), GCs (Pariante and Miller, 2001), and inflammatory processes (Dantzer et al., 2008) have been implicated in the etiology of major depression.”
BackgroundResting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827 · cited 1× · see citing works
“In the normal healthy CNS, microglia send out processes that sample the local environment at a rate of several times per second (Nimmerjahn et al., 2005) and have been termed ‘‘surveillant’’ microglia (Ransohoff and Cardona, 2010).”
BackgroundPhysiological functions of glucocorticoids in stress and their relation to pharmacological actions
MUNCK, A., GUYRE, P. M., & HOLBROOK, N. J. (1984) · Endocrine Reviews · doi:10.1210/edrv-5-1-25 · Cited by 3,083 · cited 2× · see citing works
“during an acute stressor is so obviously non-intuitive, several explanations have been offered to support why this might be rational (Munck et al., 1984).”
BackgroundDAMPs, PAMPs and alarmins: all we need to know about danger
Bianchi, M. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306164 · Cited by 2,794 · cited 3× · see citing works
“Putative alarmins include high mobility group box 1 (HMGB1), S100 proteins, heat shock proteins (HSPs), and hyaluronan (Bianchi, 2007), with HMGB1 having received the most attention to date.”
BackgroundSignaling to NF-κB by Toll-like receptors
Kawai, T., & Akira, S. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.09.002 · Cited by 2,395 · cited 2× · see citing works
“TLR4 recognizes the lipopolysaccharide (LPS) motif that is present in the cell membrane of all Gramnegative bacteria, while TLR2 recognizes lipoteichoic acid that characterizes Gram-positive bacteria (Kawai and Akira, 2007).”
BackgroundChronic stress, drug use, and vulnerability to addiction
Sinha, R. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1441.030 · Cited by 1,904 · cited 1× · see citing works
“This facilitation of drug reward processes by stress has been the subject of numerous reviews (Briand and Blendy, 2010; Koob, 2009; Sinha, 2008) and need not be reviewed here.”
BackgroundMicroglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858 · cited 2× · see citing works
“The CNS parenchyma shows very low levels of basal MHCII (Ransohoff and Perry, 2009) as well as high-level expression of CD200 (Barclay et al.”
BackgroundStress and the General Adaptation Syndrome
Selye, H. (1950) · BMJ · doi:10.1136/bmj.1.4667.1383 · Cited by 1,481 · cited 1× · see citing works
“There has been tremendous interest in the effects of stress and GCs on inflammation since the pioneering reports by Selye (1950) that ‘‘stress’’ produces thymic involution and subsequent findings that ‘‘stress’’ seemed to suppress various aspects of immune function (Selye, 1955).”
BackgroundGlucocorticoid receptors in major depression: relevance to pathophysiology and treatment
Pariante, C. M., & Miller, A. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01088-x · Cited by 1,147 · cited 2× · see citing works
“text of the present review given that stress (Anisman, 2009), GCs (Pariante and Miller, 2001), and inflammatory processes (Dantzer”
BackgroundLehnardt, S., Massillon, L., Follett, P., Jensen, F. E., Ratan, R., Rosenberg, P. A., Volpe, J. J., & Vartanian, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432609100 · Cited by 1,052 · cited 1× · see citing works
“They are sometimes reported to be present on astrocytes and sometimes to be absent, and are typically reported to be absent on neurons (Lehnardt et al., 2003).”
BackgroundThe myeloid cells of the central nervous system parenchyma
Ransohoff, R. M., & Cardona, A. E. (2010) · Nature · doi:10.1038/nature09615 · Cited by 804 · cited 5× · see citing works
“…phagocytes, constitute the predominant innate immune cell in the brain parenchyma and serve many functions including immunosurveillance of the brain microenvironment for pathogen invasion, cellular debris, apoptotic cells, and alterations in neuronal phenotype (Ransohoff and Cardona, 2010).”
BackgroundInfluentialGlucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates
Boumpas, D. T., Chrousos, G. P., Wilder, R. L., Cupps, T. R., & Balow, J. E. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-12-199312150-00007 · Cited by 765 · cited 2× · see citing works
“The subsequent discoveries of the GC hormones, and their role in mediating many of the effects of stressors, led naturally to the view that GCs are immunosuppressive in general and anti-inflammatory in particular (Boumpas et al., 1993).”
BackgroundA cell biological view of Toll-like receptor function: regulation through compartmentalization
Barton, G. M., & Kagan, J. C. (2009) · Nature reviews. Immunology · doi:10.1038/nri2587 · Cited by 713 · cited 2× · see citing works
“Of these PRRs, TLRs have been the most extensively characterized (Barton and Kagan, 2009).”
BackgroundGene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells
Galon, J., Franchimont, D., Hiroi, N., Frey, G., Boettner, A., Ehrhart-Bornstein, M., O’shea, J. J., Chrousos, G. P., & Bornstein, S. R. (2002) · The FASEB Journal · doi:10.1096/fj.01-0245com · Cited by 606 · cited 1× · see citing works
“These effects of GCs on TLR2 and TLR4 are consistent with a small literature showing that GCs up-regulate TLRs on various peripheral cell types (Galon et al., 2002; Hermoso et al., 2004; Rozkova et al., 2006; Sakai et al., 2004; Shibata et al., 2009).”
BackgroundMethamphetamine toxicity and messengers of death
Krasnova, I. N., & Cadet, J. L. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.03.002 · Cited by 589 · cited 4× · see citing works
“A considerable literature has demonstrated that Meth is neurotoxic, depending on dose and time course of administration (Krasnova and Cadet, 2009).”
BackgroundInfluentialSalminen, A., Huuskonen, J., Ojala, J., Kauppinen, A., Kaarniranta, K., & Suuronen, T. (2008) · Ageing Research Reviews · doi:10.1016/j.arr.2007.09.002 · Cited by 581 · see citing works
Pivotal role of TLR4 receptors in alcohol-induced neuroinflammation and brain damage
Alfonso-Loeches, S., Pascual-Lucas, M., Blanco, A. M., Sanchez-Vera, I., & Guerri, C. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0976-10.2010 · Cited by 579 · cited 2× · see citing works
“Importantly, TLR4 knockout (Fernandez-Lizarbe et al., 2009) and knockdown with siRNAs (Alfonso-Loeches et al., 2010) also blocked alcohol-induced neuroinflammatory responses in vivo.”
BackgroundFrank, M. G., Baratta, M. V., Sprunger, D. B., Watkins, L. R., & Maier, S. F. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.03.005 · Cited by 578 · cited 4× · see citing works
“Similar to our findings (Frank et al., 2007), chronic stress did not by itself tonically increase pro-inflammatory cytokine levels, although the activation state of microglia had been shifted toward a preferential pro-inflammatory immunophenotype.”
BackgroundResultInfluentialSelf-citationEvidence that opioids may have toll-like receptor 4 and MD-2 effects
Hutchinson, M. R., Zhang, Y., Shridhar, M., Evans, J. H., Buchanan, M. M., Zhao, T. X., Slivka, P. F., Coats, B. D., Rezvani, N., Wieseler, J. L., et al. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.08.004 · Cited by 575 · see citing works
Self-citationPerry, V. H. (2004) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2004.01.004 · Cited by 560 · cited 2× · see citing works
“Of particular relevance to the present focus, these cells can enter a state that can be called ‘‘sensitized’’ or ‘‘primed’’ (Perry, 2004).”
Qin, L., He, J., Hanes, R. N., Pluzarev, O., Hong, J.-S., & Crews, F. T. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-10 · Cited by 532 · see citing works
Increased MCP-1 and microglia in various regions of the human alcoholic brain
He, J., & Crews, F. T. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.11.017 · Cited by 516 · cited 1× · see citing works
“Indeed, microglial activation, astrogliosis, and increased expression of PICs have been observed in postmortem examination of alcoholic brains (He and Crews, 2008).”
BackgroundGlucocorticoids, stress, and their adverse neurological effects: relevance to aging
Sapolsky, R. M. (1999) · Experimental Gerontology · doi:10.1016/s0531-5565(99)00047-9 · Cited by 507 · cited 1× · see citing works
“Over the years, a number of papers have reported either no effect or even pro-inflammatory effects of GCs (Sapolsky, 1999), but these have largely been ignored.”
BackgroundMajor depression and comorbid substance use disorders
Davis, L., Uezato, A., Newell, J. M., & Frazier, E. (2008) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3282f32408 · Cited by 498 · cited 3× · see citing works
“Particularly noteworthy is the high degree of comorbidity between major depression and alcohol abuse (Davis et al., 2008).”
BackgroundInfluentialAn inflammatory review of glucocorticoid actions in the CNS
Sorrells, S. F., & Sapolsky, R. M. (2006) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.11.006 · Cited by 461 · cited 1× · see citing works
“However, this issue has recently been re-examined in a review by Sorrells and Sapolsky (2007), with the authors concluding that GCs are indeed sometimes either without effect or strongly pro-inflammatory.”
Exposure to Acute Stress Induces Brain Interleukin-1β Protein in the Rat
Nguyen, K. T., Deak, T., Owens, S. M., Kohno, T., Fleshner, M., Watkins, L. R., & Maier, S. F. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-06-02239.1998 · Cited by 460 · cited 3× · see citing works
“The first is a rapid, short duration (several hours) increase in inflammatory mediators (Nguyen et al., 1998).”
BackgroundSelf-citationThe involvement of glial cells in the development of morphine tolerance
Song, P., & Zhao, Z.-Q. (2001) · Neuroscience Research · doi:10.1016/s0168-0102(00)00226-1 · Cited by 445 · cited 2× · see citing works
“Song and Zhao found that chronic morphine activated glia in both the spinal cord and brain (Song and Zhao, 2001).”
BackgroundJohnston, I. N., Milligan, E. D., Wieseler‐Frank, J., Frank, M. G., Zapata, V., Campisi, J., Langer, S. J., Martin, D., Green, P., Fleshner, M., et al. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1850-04.2004 · Cited by 432 · cited 1× · see citing works
“In addition, blockade of morphine-induced IL-1b signaling potentiated morphine analgesia and prevented the development of hyperalgesia and morphine tolerance (Johnston et al., 2004).”
BackgroundSelf-citationInteraction between glucocorticoid hormones, stress and psychostimulant drugs*
Marinelli, M., & Piazza, P. V. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02089.x · Cited by 426 · cited 1× · see citing works
“Importantly, stress and GCs activate brain reward pathways, such as dopamine signaling in the nucleus accumbens, in a manner similar to drugs of abuse (Marinelli and Piazza, 2002).”
BackgroundCatecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines
Johnson, J. D., Campisi, J., Sharkey, C. M., Kennedy, S. L., Nickerson, M., Greenwood, B. N., & Fleshner, M. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.090 · Cited by 424 · see citing works
Mechanisms of glucocorticoid receptor signaling during inflammation
Smoak, K. A., & Cidlowski, J. A. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.06.010 · Cited by 420 · cited 2× · see citing works
“both NF-jB and AP-1 mediated gene transcription (Smoak and Cidlowski, 2004).”
BackgroundCD200 and membrane protein interactions in the control of myeloid cells
Barclay, A. N., Wright, G. J., Brooke, G. P., & Brown, M. H. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02223-8 · Cited by 416 · cited 5× · see citing works
“For example, our laboratory has shown that the microglial activation marker MHCII is up-regulated, and the neuronal glycoprotein CD200 (which constitutively constrains microglial activation, see below) is down-regulated 24 h post-stress (Frank et al., 2007).”
BackgroundInfluentialNair, A., & Bonneau, R. H. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.09.012 · Cited by 392 · cited 1× · see citing works
“For example, Nair has shown that chronic restraint stress increases microglia proliferation as well as microglia activation (Nair and Bonneau, 2006).”
BackgroundBrain stress systems in the amygdala and addiction
Koob, G. F. (2009) · Brain Research · doi:10.1016/j.brainres.2009.03.038 · Cited by 388 · cited 1× · see citing works
“This facilitation of drug reward processes by stress has been the subject of numerous reviews (Briand and Blendy, 2010; Koob, 2009; Sinha, 2008) and need not be reviewed here.”
BackgroundMethamphetamine causes microglial activation in the brains of human abusers
Sekine, Y., Ouchi, Y., Sugihara, G., Takei, N., Yoshikawa, E., Nakamura, K., Iwata, Y., Tsuchiya, K. J., Suda, S., Suzuki, K., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1179-08.2008 · Cited by 381 · cited 2× · see citing works
“…et al., 1998; Fantegrossi et al., 2008; Goncalves et al., 2010; Guilarte et al., 2003; Ladenheim et al., 2000; LaVoie et al., 2004; Pubill et al., 2003; Sekine et al., 2008; Sharma and Kiyatkin, 2009; Sriram et al., 2006; Theodore et al., 2006; Thomas et al., 2004, 2008; Thomas and Kuhn, 2005).”
BackgroundNeuroinflammation and regulation of glial glutamate uptake in neurological disorders
Tilleux, S., & Hermans, E. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21325 · Cited by 381 · cited 2× · see citing works
“…in which glial activation and the consequent release of inflammatory mediators could play a role in drug-related processes, it may be especially important that IL-1b can down-regulate the glutamate transporter GLT-1 (Tilleux and Hermans, 2007), thereby increasing glutamatergic neurotransmission.”
BackgroundCritical role of TLR4 response in the activation of microglia induced by ethanol
Fernandez-Lizarbe, S., Pascual, M., & Guerri, C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803590 · Cited by 373 · cited 5× · see citing works
“Fernandez-Lizarbe et al. (2009) found all of these to be absent in microglia taken from TLR4 deficient mice.”
BackgroundInfluentialPiazza, P. V., & Moal, M. L. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00025-8 · Cited by 372 · see citing works
Hutchinson, M. R., Bland, S. T., Johnson, K. W., Rice, K. C., Maier, S. F., & Watkins, L. R. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.230 · Cited by 359 · cited 3× · see citing works
“An emerging body of evidence suggests that activated glia and glia-derived neuroinflammatory mediators play an important role in drug reward, dependence, tolerance and analgesic properties (Hutchinson et al., 2007).”
BackgroundSelf-citationProinflammatory cytokines oppose opioid-induced acute and chronic analgesia
Hutchinson, M. R., Coats, B. D., Lewis, S. S., Zhang, Y., Sprunger, D. B., Rezvani, N., Baker, E. M., Jekich, B. M., Wieseler, J. L., Somogyi, A. A., et al. (2008) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2008.05.004 · Cited by 307 · see citing works
Self-citationFrank, M. G., Miguel, Z. D., Watkins, L. R., & Maier, S. F. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.07.008 · Cited by 303 · cited 16× · see citing works
“Lastly, drugs of abuse signal through TLRs (see below for discussion).”
BackgroundInfluentialSelf-citationHutchinson, M. R., Lewis, S. S., Coats, B. D., Skyba, D. A., Crysdale, N. Y., Berkelhammer, D. L., Brzeski, A., Northcutt, A. L., Vietz, C. M., Judd, C. M., et al. (2008) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2008.09.012 · Cited by 301 · see citing works
Self-citationMaier, S. F. (2003) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(03)00032-1 · Cited by 300 · cited 2× · see citing works
“similar profile of pro-inflammatory ‘‘cytokine signatures’’ in the CNS (Maier, 2003).”
Self-citationAnisman, H. (2009) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0902 · Cited by 292 · cited 3× · see citing works
“text of the present review given that stress (Anisman, 2009), GCs (Pariante and Miller, 2001), and inflammatory processes (Dantzer”
BackgroundThe IκB kinase complex: master regulator of NF-κB signaling
Solt, L. A., & May, M. J. (2008) · Immunologic Research · doi:10.1007/s12026-008-8025-1 · Cited by 284 · cited 2× · see citing works
“these transcription factors, particularly NF-jB, are the key regulators of inflammatory genes (Solt and May, 2008).”
BackgroundMunhoz, C. D., Lepsch, L. B., Kawamoto, E. M., Malta, M. B., Lima, L. D. S., Werneck Avellar, M. C., Sapolsky, R. M., & Scavone, C. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4398-05.2006 · Cited by 274 · see citing works
Vallés, S. L., Blanco, A. M., Pascual, M., & Guerri, C. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00079.x · Cited by 271 · cited 9× · see citing works
“Although a variety of mechanisms have been implicated, it is agreed that GCs inhibit both NF-jB and AP-1 mediated gene transcription (Smoak and Cidlowski, 2004).”
BackgroundInfluentialRaghavendra, V., Tanga, F. Y., & DeLeo, J. A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300315 · Cited by 263 · cited 8× · see citing works
“In vivo GC treatment potentiated the PIC (IL-1b, TNFa) response to LPS ex vivo in a dose dependent manner.”
BackgroundInfluentialBlanco, A. M., Vallés, S. L., Pascual, M., & Guerri, C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6893 · Cited by 258 · cited 2× · see citing works
“In vitro, even a brief exposure to alcohol at physiological concentrations (50 nM) induces inflammatory processes in astrocytes (Blanco et al., 2005) and microglia (Fernandez-Lizarbe et al., 2009).”
BackgroundImmobilization stress induces interleukin-1β mRNA in the rat hypothalamus
Minami, M., Kuraishi, Y., Yamaguchi, T., Nakai, S., Hirai, Y., & Satoh, M. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90944-o · Cited by 258 · cited 1× · see citing works
“Indeed, a considerable literature shows that several different kinds of stressors induce pro-inflammatory cytokines in the CNS (Anisman, 2009; Hennessy et al., 2009; Minami et al., 1991; Shintani et al., 1995).”
BackgroundPeripheral and central proinflammatory cytokine response to a severe acute stressor
O'Connor, K. A., Johnson, J. D., Hansen, M. K., Wieseler Frank, J. L., Maksimova, E., Watkins, L. R., & Maier, S. F. (2003) · Brain Research · doi:10.1016/j.brainres.2003.08.006 · Cited by 247 · cited 1× · see citing works
“Brain levels of pro-inflammatory cytokines are already elevated immediately after a moderate duration ( 2 h) of stress (O’Connor et al., 2003) and persist for 4–6 h.”
BackgroundSelf-citationShintani, F., Nakaki, T., Kanba, S., Sato, K., Yagi, G., Shiozawa, M., Aiso, S., Kato, R., & Asai, M. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-03-01961.1995 · Cited by 245 · cited 1× · see citing works
“Indeed, a considerable literature shows that several different kinds of stressors induce pro-inflammatory cytokines in the CNS (Anisman, 2009; Hennessy et al., 2009; Minami et al., 1991; Shintani et al., 1995).”
BackgroundSriram, K., Miller, D. B., & O'Callaghan, J. P. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03566.x · Cited by 242 · cited 2× · see citing works
“…et al., 1998; Fantegrossi et al., 2008; Goncalves et al., 2010; Guilarte et al., 2003; Ladenheim et al., 2000; LaVoie et al., 2004; Pubill et al., 2003; Sekine et al., 2008; Sharma and Kiyatkin, 2009; Sriram et al., 2006; Theodore et al., 2006; Thomas et al., 2004, 2008; Thomas and Kuhn, 2005).”
BackgroundFleshner, M., Terrence Deak, B., Spencer, R. L., Laudenslager, M. L., Watkins, L. R., & Maier, S. F. (1995) · Endocrinology · doi:10.1210/endo.136.12.7588279 · Cited by 235 · cited 2× · see citing works
“In fact, we have found that serum GC levels rise rapidly during the initial stress and return to baseline within 2–6 h after the stressor used in the above studies (Fleshner et al., 1995).”
BackgroundSelf-citationMolecular Bases of Methamphetamine-Induced Neurodegeneration
Cadet, J. L., & Krasnova, I. N. (2009) · International review of neurobiology · doi:10.1016/s0074-7742(09)88005-7 · Cited by 227 · cited 2× · see citing works
“flammatory effects including PIC, chemokines, and oxidative stress (Cadet and Krasnova, 2009; Krasnova and Cadet, 2009).”
BackgroundNarita, M., Miyatake, M., Narita, M., Shibasaki, M., Shindo, K., Nakamura, A., Kuzumaki, N., Nagumo, Y., & Suzuki, T. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301007 · Cited by 218 · see citing works
Pollak, Y., & Yirmiya, R. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003152 · Cited by 215 · cited 1× · see citing works
“Of note, pro-inflammatory cytokines administered to humans induce depression-like symptoms (Pollak and Yirmiya, 2002).”
BackgroundStress increases vulnerability to inflammation in the rat prefrontal cortex
de Pablos, R. M., Villarán, R. F., Argüelles, S., Herrera, A. J., Venero, J. L., Ayala, A., Cano, J., & Machado, A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0802-06.2006 · Cited by 215 · cited 1× · see citing works
“The stressor regimen facilitated LPS-induced microglial activation (MHCII expression) and cytokine expression; such effects were blocked by daily RU486 (de Pablos et al., 2006).”
BackgroundMicroglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity
LaVoie, M. J., Card, J. P., & Hastings, T. G. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.01.010 · Cited by 204 · cited 1× · see citing works
“…2006; Buchanan et al., 2010; Escubedo et al., 1998; Fantegrossi et al., 2008; Goncalves et al., 2010; Guilarte et al., 2003; Ladenheim et al., 2000; LaVoie et al., 2004; Pubill et al., 2003; Sekine et al., 2008; Sharma and Kiyatkin, 2009; Sriram et al., 2006; Theodore et al., 2006; Thomas et al.,…”
BackgroundMorphine-6-glucuronide: Analgesic effects and receptor binding profile in rats
Abbott, F. V., & Palmour, R. M. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90479-1 · Cited by 195 · cited 2× · see citing works
“This dissociation of metabolite characteristics was very interesting as the metabolite that had no attraction to TLR4–MD2 was morphine-6-glucuronide (M6G), which binds opioid receptors avidly and produces potent analgesia (Abbott and Palmour, 1988).”
BackgroundMicroglial activation is a pharmacologically specific marker for the neurotoxic amphetamines
Thomas, D. M., Dowgiert, J., Geddes, T. J., Francescutti, D. M., Liu, X., & Kuhn, D. M. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.06.065 · Cited by 193 · cited 1× · see citing works
“…et al., 1998; Fantegrossi et al., 2008; Goncalves et al., 2010; Guilarte et al., 2003; Ladenheim et al., 2000; LaVoie et al., 2004; Pubill et al., 2003; Sekine et al., 2008; Sharma and Kiyatkin, 2009; Sriram et al., 2006; Theodore et al., 2006; Thomas et al., 2004, 2008; Thomas and Kuhn, 2005).”
BackgroundKoning, N., Swaab, D. F., Hoek, R. M., & Huitinga, I. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181964113 · Cited by 188 · cited 1× · see citing works
“CD200 functions to inhibit microglia and other CNS macrophages through the CD200 receptor expressed predominately on brain macrophages/microglia (Barclay et al., 2002; Koning et al., 2009), thereby constraining the onset of proinflammatory processes.”
BackgroundLewis, S. S., Hutchinson, M. R., Rezvani, N., Loram, L. C., Zhang, Y., Maier, S. F., Rice, K. C., & Watkins, L. R. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.10.011 · Cited by 184 · see citing works
Self-citationHutchinson, M. R., Lewis, S. S., Coats, B. D., Rezvani, N., Zhang, Y., Wieseler, J. L., Somogyi, A. A., Yin, H., Maier, S. F., Rice, K. C., et al. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.02.011 · Cited by 181 · cited 3× · see citing works
“…withdrawal behaviors while potentiating morphine’s analgesic properties (Hutchinson et al., 2009) Importantly, in line with such observations, we demonstrated that TLR4 knock out mice exhibit enhanced morphine analgesia and attenuated development of morphine tolerance (Hutchinson et al., 2010b).”
BackgroundInfluentialSelf-citationGlial toll-like receptor signaling in central nervous system infection and autoimmunity
Carpentier, P. A., Duncan, D. S., & Miller, S. D. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.08.011 · Cited by 178 · cited 1× · see citing works
“First, microglia express many of the TLRs characterized in rodents (Carpentier et al., 2008) (13 in all).”
BackgroundHermoso, M. A., Matsuguchi, T., Smoak, K. A., & Cidlowski, J. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.11.4743-4756.2004 · Cited by 177 · cited 1× · see citing works
“These effects of GCs on TLR2 and TLR4 are consistent with a small literature showing that GCs up-regulate TLRs on various peripheral cell types (Galon et al., 2002; Hermoso et al., 2004; Rozkova et al., 2006; Sakai et al., 2004; Shibata et al., 2009).”
BackgroundRole of Tumor Necrosis Factor-α in Methamphetamine-Induced Drug Dependence and Neurotoxicity
Nakajima, A., Yamada, K., Nagai, T., Uchiyama, T., Miyamoto, Y., Mamiya, T., He, J., Nitta, A., Mizuno, M., Tran, M. H., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4847-03.2004 · Cited by 176 · cited 1× · see citing works
“Consistent with several studies cited above, repeated Meth treatment in- creased TNFa throughout the brain (Nakajima et al., 2004).”
ResultToll-like Receptors in Defense and Damage of the Central Nervous System
Aravalli, R. N., Peterson, P. K., & Lokensgard, J. R. (2007) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-007-9071-5 · Cited by 173 · cited 2× · see citing works
“TLR2 and TLR4 have been the most intensively studied PRRs within the CNS, and are densely expressed on microglial cells (Aravalli et al., 2007).”
BackgroundMcKay, L. I., & Cidlowski, J. A. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.8.0506 · Cited by 169 · cited 1× · see citing works
“For example, activated glucocorticoid receptors (GRs) induce IkBalpha expression, preventing NF-jB translocation to the nucleus (Aljada et al., 1999) and also block NF-jB binding activity via interactions with the NF-jB p65 subunit (McKay and Cidlowski, 2000).”
BackgroundMunhoz, C. D., Sorrells, S. F., Caso, J. R., Scavone, C., & Sapolsky, R. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0303-09.2010 · Cited by 169 · see citing works
Rožková, D., Horváth, R., Bartůňková, J., & Špíšek, R. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.04.567 · Cited by 164 · cited 1× · see citing works
“These effects of GCs on TLR2 and TLR4 are consistent with a small literature showing that GCs up-regulate TLRs on various peripheral cell types (Galon et al., 2002; Hermoso et al., 2004; Rozkova et al., 2006; Sakai et al., 2004; Shibata et al., 2009).”
BackgroundAttenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice
Mika, J., Wawrzczak‐Bargieła, A., Osikowicz, M., Makuch, W., & Przewłocka, B. (2008) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2008.07.005 · Cited by 163 · cited 1× · see citing works
“Consistent with these findings, glial inhibition potentiated morphine analgesia and attenuated morphine tolerance (Mika et al., 2009).”
ResultBowyer, J. F., & Ali, S. F. (2006) · Synapse · doi:10.1002/syn.20324 · Cited by 162 · see citing works
Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity
Pubill, D., Canudas, A. M., Pallàs, M., Camins, A., Camarasa, J., & Escubedo, E. (2003) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-003-0747-y · Cited by 160 · cited 1× · see citing works
“…2010; Escubedo et al., 1998; Fantegrossi et al., 2008; Goncalves et al., 2010; Guilarte et al., 2003; Ladenheim et al., 2000; LaVoie et al., 2004; Pubill et al., 2003; Sekine et al., 2008; Sharma and Kiyatkin, 2009; Sriram et al., 2006; Theodore et al., 2006; Thomas et al., 2004, 2008; Thomas…”
BackgroundThe glial activation inhibitor AV411 reduces morphine-induced nucleus accumbens dopamine release
Bland, S. T., Hutchinson, M. R., Maier, S. F., Watkins, L. R., & Johnson, K. W. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.01.014 · Cited by 152 · cited 3× · see citing works
“dopamine efflux in the nucleus accumbens (Bland et al., 2009; Northcutt et al., 2010).”
BackgroundSelf-citationGonçalves, J., Baptista, S., Martins, T., Milhazes, N., Borges, F., Ribeiro, C. F., Malva, J. O., & Silva, A. P. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07059.x · Cited by 152 · cited 2× · see citing works
“…number of reports show that Meth activates microglia (Bowyer and Ali, 2006; Buchanan et al., 2010; Escubedo et al., 1998; Fantegrossi et al., 2008; Goncalves et al., 2010; Guilarte et al., 2003; Ladenheim et al., 2000; LaVoie et al., 2004; Pubill et al., 2003; Sekine et al., 2008; Sharma and…”
BackgroundStress is critical for LPS-induced activation of microglia and damage in the rat hippocampus
Espinosa-Oliva, A. M., de Pablos, R. M., Villarán, R. F., Argüelles, S., Venero, J. L., Machado, A., & Cano, J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.01.012 · Cited by 151 · cited 2× · see citing works
“…for 9 days resulted in microglia activation (as reflected by increased MHCII expression) and potentiated the neuroinflammatory response (IL-1b, tumor necrosis factor (TNF)a, nitric oxide synthase (NOS), inducible (i)NOS and p38 MAPK) to intra-hippocampal LPS (Espinosa-Oliva et al., 2011).”
BackgroundNguyen, K. T., Deak, T., Will, M. J., Hansen, M. K., Hunsaker, B. N., Fleshner, M., Watkins, L. R., & Maier, S. F. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02443-9 · Cited by 143 · cited 2× · see citing works
“, 1998) and GC injection before the stressor inhibits it (Nguyen et al., 2000).”
BackgroundSelf-citationEffects of prior stress on LPS-induced cytokine and sickness responses
Johnson, J. D., O'Connor, K. A., Hansen, M. K., Watkins, L. R., & Maier, S. F. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00230.2002 · Cited by 138 · see citing works
Self-citationArmario, A. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.04.005 · Cited by 131 · cited 1× · see citing works
“Further, drugs of abuse activate the hypothalamo-pituitary–adrenal (HPA) axis (Armario, 2010).”
BackgroundLadenheim, B., Krasnova, I. N., Deng, X., Oyler, J. M., Polettini, A., Moran, T. H., Huestis, M. A., & Cadet, J. L. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.6.1247 · Cited by 131 · cited 3× · see citing works
“dative stress, and neurotoxicity in several brain regions including the striatum, frontal cortex, and hippocampus (Ladenheim et al., 2000).”
BackgroundInfluentialSignaling the brain in systemic inflammation the role of perivascular cells
Sawchenko, P. E. (2003) · Frontiers in bioscience · doi:10.2741/1211 · Cited by 129 · cited 1× · see citing works
“These macrophage subtypes also serve a critical role in the brain’s innate immune response (Schiltz and Sawchenko, 2003) and may potentially contribute to the processes under discussion, but will not be further addressed here.”
BackgroundGoujon, E., Parnet, P., Layé, S., Combe, C., & Dantzer, R. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(95)00242-k · Cited by 128 · cited 1× · see citing works
“These same points can be made with regard to the immediate neuroinflammatory response to immune activators such as LPS (Goujon et al., 1996).”
BackgroundMolecular and genetic substrates linking stress and addiction
Briand, L. A., & Blendy, J. A. (2010) · Brain Research · doi:10.1016/j.brainres.2009.11.002 · Cited by 125 · cited 1× · see citing works
“This facilitation of drug reward processes by stress has been the subject of numerous reviews (Briand and Blendy, 2010; Koob, 2009; Sinha, 2008) and need not be reviewed here.”
BackgroundGuilarte, T. R., Nihei, M. K., McGlothan, J. L., & Howard, A. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00476-7 · Cited by 125 · cited 1× · see citing works
“…that Meth activates microglia (Bowyer and Ali, 2006; Buchanan et al., 2010; Escubedo et al., 1998; Fantegrossi et al., 2008; Goncalves et al., 2010; Guilarte et al., 2003; Ladenheim et al., 2000; LaVoie et al., 2004; Pubill et al., 2003; Sekine et al., 2008; Sharma and Kiyatkin, 2009; Sriram et…”
BackgroundMagnitude and impact of comorbidity of mental disorders from epidemiologic surveys
Merikangas, K. R., & Kalaydjian, A. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3281c61dc5 · Cited by 122 · cited 1× · see citing works
“Briefly, a considerable literature has documented the high degree of comorbidity between substance abuse and psychiatric disorders (Merikangas and Kalaydjian, 2007).”
BackgroundSHARMA, H. S., & Kiyatkin, E. A. (2008) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2008.08.002 · Cited by 118 · cited 1× · see citing works
“…et al., 1998; Fantegrossi et al., 2008; Goncalves et al., 2010; Guilarte et al., 2003; Ladenheim et al., 2000; LaVoie et al., 2004; Pubill et al., 2003; Sekine et al., 2008; Sharma and Kiyatkin, 2009; Sriram et al., 2006; Theodore et al., 2006; Thomas et al., 2004, 2008; Thomas and Kuhn, 2005).”
BackgroundShibata, M., Katsuyama, M., Onodera, T., Ehama, R., Hosoi, J., & Tagami, H. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.237 · Cited by 116 · cited 1× · see citing works
“These effects of GCs on TLR2 and TLR4 are consistent with a small literature showing that GCs up-regulate TLRs on various peripheral cell types (Galon et al., 2002; Hermoso et al., 2004; Rozkova et al., 2006; Sakai et al., 2004; Shibata et al., 2009).”
BackgroundMorphine in Postoperative Patients: Pharmacokinetics and Pharmacodynamics of Metabolites
Mazoit, J. X., Butscher, K., & Samii, K. (2007) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000265557.73688.32 · Cited by 110 · cited 1× · see citing works
“This profile of long-lived presence plus potent pain enhancement has gained focus on M3G as an attenuator of the pain-relieving effects of its parent compound, morphine, and an important contributor to the development of morphine tolerance (Mazoit et al., 2007).”
BackgroundFantegrossi, W. E., Ciullo, J. R., Wakabayashi, K. T., Garza, R. D. L., Traynor, J. R., & Woods, J. H. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.11.007 · Cited by 101 · cited 1× · see citing works
“A considerable number of reports show that Meth activates microglia (Bowyer and Ali, 2006; Buchanan et al., 2010; Escubedo et al., 1998; Fantegrossi et al., 2008; Goncalves et al., 2010; Guilarte et al., 2003; Ladenheim et al., 2000; LaVoie et al., 2004; Pubill et al., 2003; Sekine et al., 2008;…”
BackgroundFlora, G., Lee, Y. W., Nath, A., Hennig, B., Maragos, W., & Toborek, M. (2003) · Experimental Neurology · doi:10.1006/exnr.2002.8048 · Cited by 99 · cited 1× · see citing works
“Likewise, acute Meth increased TNFa and IL-1b in striatum and potentiated cytokine response to HIV TAT (Flora et al., 2003), as well as the chemokine expression to the HIV Tat protein (Theodore et al., 2006).”
BackgroundBeardsley, P. M., Shelton, K. L., Hendrick, E., & Johnson, K. W. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.04.010 · Cited by 97 · cited 1× · see citing works
“Lastly, treatment with the glial inhibitor, Ibudilast (a drug used extensively in our laboratory to modulate the pro-inflammatory effects of morphine; see above), attenuated stress-induced reinstatement of extinguished Meth-maintained responding (Beardsley et al., 2010).”
BackgroundAttenuated microglial activation mediates tolerance to the neurotoxic effects of methamphetamine
Thomas, D. M., & Kuhn, D. M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02906.x · Cited by 95 · cited 1× · see citing works
“…et al., 1998; Fantegrossi et al., 2008; Goncalves et al., 2010; Guilarte et al., 2003; Ladenheim et al., 2000; LaVoie et al., 2004; Pubill et al., 2003; Sekine et al., 2008; Sharma and Kiyatkin, 2009; Sriram et al., 2006; Theodore et al., 2006; Thomas et al., 2004, 2008; Thomas and Kuhn, 2005).”
BackgroundBlanco, A. M. A., Pérez-Aragó, A., Fernández‐Lizarbe, S., & Guerri, C. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05425.x · Cited by 92 · cited 1× · see citing works
“For example, it has been suggested (Blanco et al., 2008) that alcohol interacts with lipid rafts in such a way that TLR4 is recruited, triggering its endocytosis and interaction with co-signaling molecules such as MD2, and the consequent induction of downstream signaling.”
BackgroundToborek, M., Flora, G., Lee, Y. W., Nath, A., Maragos, W., & Hennig, B. (2002) · NeuroMolecular Medicine · doi:10.1385/nmm:2:1:71 · Cited by 89 · cited 12× · see citing works
“In vivo GC treatment potentiated the PIC (IL-1b, TNFa) response to LPS ex vivo in a dose dependent manner.”
BackgroundInfluentialSakai, A., Han, J., Cato, A. C. B., Akira, S., & Li, J. (2004) · BMC Molecular Biology · doi:10.1186/1471-2199-5-2 · Cited by 83 · cited 1× · see citing works
“These effects of GCs on TLR2 and TLR4 are consistent with a small literature showing that GCs up-regulate TLRs on various peripheral cell types (Galon et al., 2002; Hermoso et al., 2004; Rozkova et al., 2006; Sakai et al., 2004; Shibata et al., 2009).”
BackgroundMicrogliosis and down-regulation of adenosine transporter induced by methamphetamine in rats
Escubedo, E., Guitart, L., Sureda, F. X., Jiménez, A., Pubill, D., Pallàs, M., Camins, A., & Camarasa, J. (1998) · Brain Research · doi:10.1016/s0006-8993(98)01065-8 · Cited by 79 · cited 1× · see citing works
“A considerable number of reports show that Meth activates microglia (Bowyer and Ali, 2006; Buchanan et al., 2010; Escubedo et al., 1998; Fantegrossi et al., 2008; Goncalves et al., 2010; Guilarte et al., 2003; Ladenheim et al., 2000; LaVoie et al., 2004; Pubill et al., 2003; Sekine et al., 2008;…”
BackgroundBartlett, S. E., Dodd, P. R., & Smith, M. T. (1994) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1994.tb00327.x · Cited by 68 · cited 2× · see citing works
“enhancement by as-yet-to-be-discovered mechanisms (Bartlett et al., 1994).”
BackgroundMethamphetamine-induced expression of interleukin-1β mRNA in the rat hypothalamus
Yamaguchi, T., Kuraishi, Y., Minami, M., Nakai, S., Hirai, Y., & Satoh, M. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90766-m · Cited by 65 · see citing works
Glucocorticoids and Vulnerability to Psychostimulant Drugs: Toward Substrate and Mechanism
de Jong, I. E. M., & de Kloet, E. R. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1296.022 · Cited by 63 · see citing works
Tata, D. Α., & Yamamoto, B. K. (2008) · Synapse · doi:10.1002/syn.20497 · Cited by 54 · cited 1× · see citing works
“Prior chronic stress was also found to potentiate the hyperthermic response to Meth, which was blocked by treating animals with the glucocorticoid synthesis inhibitor, metyrapone, during chronic stress exposure (Tata and Yamamoto, 2008).”
BackgroundAljada, A., Ghanim, H., Assian, E., Mohanty, P., Hamouda, W., Garg, R., & Dandona, P. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.9.6104 · Cited by 50 · cited 1× · see citing works
“For example, activated glucocorticoid receptors (GRs) induce IkBalpha expression, preventing NF-jB translocation to the nucleus (Aljada et al., 1999) and also block NF-jB binding activity via interactions with the NF-jB p65 subunit (McKay and Cidlowski, 2000).”
BackgroundChronic stress augments the long-term and acute effects of methamphetamine
Matuszewich, L., & Yamamoto, B. K. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.12.007 · Cited by 49 · cited 1× · see citing works
“A regimen of chronic unpredictable stress potentiated the hyperthermic response to Meth (Matuszewich and Yamamoto, 2004).”
BackgroundDer-Avakian, A., Will, M. J., Bland, S. T., Deak, T., Nguyen, K. T., Schmid, M. J., Spencer, R. L., Watkins, L. R., & Maier, S. F. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2041-1 · Cited by 47 · cited 2× · see citing works
“Our laboratory has also found that stress as well as GCs sensitizes the rewarding properties of morphine, and that just as with stress-induced potentiation of later inflammatory responses to immune activation, adrenalectomy blocks stress-induced potentiation of drug reward (Der-Avakian et al., 2005).”
BackgroundSelf-citationThomas, D. M., Francescutti, D. M., & Kuhn, D. M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05421.x · Cited by 43 · cited 1× · see citing works
“…et al., 1998; Fantegrossi et al., 2008; Goncalves et al., 2010; Guilarte et al., 2003; Ladenheim et al., 2000; LaVoie et al., 2004; Pubill et al., 2003; Sekine et al., 2008; Sharma and Kiyatkin, 2009; Sriram et al., 2006; Theodore et al., 2006; Thomas et al., 2004, 2008; Thomas and Kuhn, 2005).”
BackgroundBuchanan, J. B., Sparkman, N. L., & Johnson, R. W. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-82 · Cited by 35 · cited 3× · see citing works
“including striatum, hypothalamus, hippocampus, cortex, and cerebellum, and prior Meth also potentiated the microglial activation induced by LPS (Buchanan et al., 2010).”
BackgroundSeparation, Sickness, and Depression
Hennessy, M. B., Schiml‐Webb, P. A., & Terrence Deak, B. (2009) · Current Directions in Psychological Science · doi:10.1111/j.1467-8721.2009.01641.x · Cited by 33 · cited 1× · see citing works
“Indeed, a considerable literature shows that several different kinds of stressors induce pro-inflammatory cytokines in the CNS (Anisman, 2009; Hennessy et al., 2009; Minami et al., 1991; Shintani et al., 1995).”
BackgroundLai, Y.-T., Tsai, Y.-P. N., Cherng, C. G., Ke, J.-J., Ho, M.-C., Tsai, C.-W., & Yu, L. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0204-2 · Cited by 29 · cited 2× · see citing works
“In rhesus monkeys, chronic Meth increased interferon a/b in frontal lobe (Coutinho et al., 2008) and striatal expression of TNF and NF-jB (Lai et al., 2009).”
BackgroundHuman immunodeficiency virus-1 protein tat and methamphetamine interactions
THEODORE, S., STOLBERG, S., CASS, W. A., & MARAGOS, W. F. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1369.018 · Cited by 27 · cited 3× · see citing works
“…et al., 1998; Fantegrossi et al., 2008; Goncalves et al., 2010; Guilarte et al., 2003; Ladenheim et al., 2000; LaVoie et al., 2004; Pubill et al., 2003; Sekine et al., 2008; Sharma and Kiyatkin, 2009; Sriram et al., 2006; Theodore et al., 2006; Thomas et al., 2004, 2008; Thomas and Kuhn, 2005).”
BackgroundCoutinho, A., Flynn, C., Burdo, T. H., Mervis, R. F., & Fox, H. S. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9113-7 · Cited by 16 · cited 2× · see citing works
“In rhesus monkeys, chronic Meth increased interferon a/b in frontal lobe (Coutinho et al., 2008) and striatal expression of TNF and NF-jB (Lai et al.”
BackgroundAljada, A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.9.3386 · Cited by 16 · see citing works
Yamaguchi, T., Kuraishi, Y., Yabuuchi, K., Minami, M., & Satoh, M. (1991) · Molecular and Cellular Neuroscience · doi:10.1016/1044-7431(91)90053-q · Cited by 13 · cited 10× · see citing works
“What our group has discovered is that the strong attraction of M3G to the key TLR4–MD2 binding pocket is paralleled by: (a) activation of TLR4 receptor signaling, blocked by LPS-RS (LPS derived from Rhodobacter sphaeroides), a classic TLR4 antagonist, (b) stimulation by M3G of IL-1b production in microglial cells, and…”
BackgroundInfluentialMiller, A. H. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.06.003 · Cited by 6 · cited 1× · see citing works
“Their review has elicited a great deal of controversy (e.g. see comment, Miller, 2007) because the conclusion that GCs are anti-inflammatory is strongly entrenched, and the issue is of great importance both theoretically and clinically.”
Background"Critical Period" for Inhibition of Inflammation by a Primarily Neurogenic Stress-Situation
Selye, H. (1955) · Psychosomatic Medicine · doi:10.1097/00006842-195503000-00004 · Cited by 5 · cited 1× · see citing works
“There has been tremendous interest in the effects of stress and GCs on inflammation since the pioneering reports by Selye (1950) that ‘‘stress’’ produces thymic involution and subsequent findings that ‘‘stress’’ seemed to suppress various aspects of immune function (Selye, 1955).”
BackgroundNovel toll like receptor 4 (TLR4) involvement in drug reward
Northcutt, A. L., Stregola, C., Bland, S. T., Amat, J., Hutchinson, M. R., Miles, N. E., Rosezke, R., Loeffler, M., Maier, S. F., Rice, K., et al. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.07.040 · Cited by 3 · see citing works
Self-citation
Flagged first, then by citations
2 of the 120 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Nusslock, R., & Miller, G. E. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.05.017 · Cited by 672 · see citing works
Pan, Y., Chen, X.-Y., Zhang, Q.-Y., & Kong, L.-D. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.04.007 · Cited by 405 · see citing works
“Recently, some studies have shown that glucocorticoid pretreatment sensitizes inflammatory response in the CNS (Frank et al., 2011, 2012), which is previously considered as the events of glucocorticoid resistance in depression.”
BackgroundLobo, M. K., & Nestler, E. J. (2011) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2011.00041 · Cited by 371 · see citing works
“In particular, disrupting glucocorticoid signaling in D1+ MSNs by deleting Nr3c1 diminished the motivation these mice display to self-administer cocaine, and this is consistent with previous data where Nr3c1 was deleted from the entire brain (Ambroggi et al., 2009).”
BackgroundResultInduction of innate immune genes in brain create the neurobiology of addiction
Crews, F. T., Zou, J., & Qin, L. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.03.003 · Cited by 313 · see citing works
Li, H., Xiang, Y., Zhu, Z., Wang, W., Jiang, Z., Zhao, M., Cheng, S., Pan, F., Liu, D., Ho, R., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02303-y · Cited by 255 · see citing works
“Chronic stress and glucocorticoid signaling can induce dendritic atrophy and functional changes in microglia which contribute to the deficits of behavior and cognition [50, 51].”
BackgroundToll-like receptors in chronic pain
Nicotra, L. L., Loram, L. C., Watkins, L. R., & Hutchinson, M. R. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.09.038 · Cited by 250 · see citing works
“Glial priming however, has not only been demonstrated after trauma, but also as a consequence of exposure to environmental stressors (Frank et al., 2011).”
BackgroundSelf-citationde Pablos, R. M., Herrera, A. J., Espinosa-Oliva, A. M., Sarmiento, M., Muñoz, M. F., Machado, A., & Venero, J. L. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-34 · Cited by 201 · see citing works
“When priming does occur in microglia or peripheral macrophages, these sensitised cells do not produce proinflammatory or antiinflammatory products, but, if further stimulated, they produce high levels of proinflammatory products [69-75].”
BackgroundPascual, M., Baliño, P., Aragón, C. M. G., & Guerri, C. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.014 · Cited by 201 · see citing works
Early life stress perturbs the maturation of microglia in the developing hippocampus
Delpech, J.-C., Wei, L., Hao, J., Yu, X., Madore, C., Butovsky, O., & Kaffman, A. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.06.006 · Cited by 193 · see citing works
Maternal Stress and Effects of Prenatal Air Pollution on Offspring Mental Health Outcomes in Mice
Bolton, J. L., Huff, N. C., Smith, S. H., Mason, S. N., Foster, W. M., Auten, R. L., & Bilbo, S. D. (2013) · Environmental Health Perspectives · doi:10.1289/ehp.1306560 · Cited by 191 · see citing works
“Notably, prior stress has been shown to enhance pro inflammatory cytokine expression and associated neural damage following an immune challenge in adult rats (De Pablos et al. 2006), most likely by sensitizing micro glia (Frank et al. 2011).”
BackgroundInfluentialRegulatory and Mechanistic Actions of Glucocorticoids on T and Inflammatory Cells
Liberman, A. C., Budziñski, M. L., Sokn, C., Gobbini, R. P., Steininger, A., & ARZT, E. S. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00235 · Cited by 185 · see citing works
Neural Regulation of the Stress Response: The Many Faces of Feedback
Myers, B., McKlveen, J. M., & Herman, J. P. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-012-9801-y · Cited by 175 · see citing works
“In addition, sensitization of reward pathways due to aberrant HPA axis activity has been proposed to drive vulnerability to addictive disorders, as GCs promote perseverance of addictive behavior (de Jong and de Kloet 2004; Uhart and Wand 2009; Frank et al. 2011).”
Neuron–Microglia Interactions in Mental Health Disorders: “For Better, and For Worse”
Wohleb, E. S. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00544 · Cited by 164 · see citing works
Neuroimmune Mechanisms of Alcohol and Drug Addiction
Cui, C., Shurtleff, D., & Harris, R. A. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801284-0.00001-4 · Cited by 163 · see citing works
Sobesky, J. L., Barrientos, R. M., May, H. S. D., Thompson, B. M., Weber, M. D., Watkins, L. R., & Maier, S. F. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.06.017 · Cited by 160 · see citing works
“In addition, there is growing evidence that certain conditions, such as stress (Johnson et al., 2003; Li et al., 2008; Frank et al., 2011; Loram et al., 2011), peripheral inflammation (Perry et al., 2007; Dantzer et al., 2008; Williamson et al., 2011), and advanced age (Barrientos et al., 2006;…”
Self-citationHerbert, J., & Lucassen, P. J. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2015.12.001 · Cited by 150 · see citing works
“This enhancement was reversed by the GR antagonist mifepristone, showing that it was the result of elevated corticosterone (de Pablos et al., 2014); a similar enhancement of microglial activity was observed following corticosterone treat-ment (Frank et al., 2011).”
BackgroundBell, R. L., Lopez, M. F., Cui, C., Egli, M., Johnson, K. W., Franklin, K. M., & Becker, H. C. (2015) · Addiction Biology · doi:10.1111/adb.12106 · Cited by 138 · see citing works
“Indeed, neuroimmune modulation via microglial and astroglial cells may contribute to stress-induced drug reinstatement (Frank et al., 2011).”
Liu, J., Buisman-Pijlman, F., & Hutchinson, M. R. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00309 · Cited by 119 · see citing works
“The immune-priming effect of stress is proposed to mediate stress-induced side effects such as allodynia (Loram et al., 2011), and drug abuse (Frank et al., 2011), and could potentially be involved in MDD as well.”
BackgroundRay, L. A., Bujarski, S., Shoptaw, S., Roche, D. J., Heinzerling, K., & Miotto, K. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.10 · Cited by 118 · see citing works
Bell, I. R., & Koithan, M. S. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-191 · Cited by 109 · see citing works
“The growth in magnitude of the response derives from TDS-based amplifications in the physiological adaptations of the organism, not directly from the size of the initiating stimulus or stressor.”
BackgroundInfluentialHorchar, M. J., & Wohleb, E. S. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.06.030 · Cited by 96 · see citing works
Chabry, J., Nicolas, S., Cazareth, J., Murris, E., Guyon, A., Glaichenhaus, N., Heurteaux, C., & Petit-Paitel, A. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.07.018 · Cited by 96 · see citing works
Glucocorticoids regulate natural killer cell function epigenetically
Eddy, J. L., Krukowski, K., Janusek, L. W., & Mathews, H. L. (2014) · Cellular Immunology · doi:10.1016/j.cellimm.2014.05.013 · Cited by 93 · see citing works
“Even though GC are known to suppress immune function under some conditions, GC under other conditions can promote immune responsiveness [20; 21; 22; 23; 24].”
BackgroundHostinar, C. E., Nusslock, R., & Miller, G. E. (2018) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2016.1266647 · Cited by 90 · see citing works
Finnell, J. E., Lombard, C. M., Melson, M. N., Singh, N. P., Nagarkatti, M., Nagarkatti, P. S., Fadel, J. R., Wood, C. S., & Wood, S. K. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.08.019 · Cited by 86 · see citing works
Glial Modulators as Potential Treatments of Psychostimulant Abuse
Beardsley, P. M., & Hauser, K. F. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-420118-7.00001-9 · Cited by 82 · see citing works
Kelly, K. A., Miller, D. B., Bowyer, J. F., & O'Callaghan, J. P. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07864.x · Cited by 82 · see citing works
Doyon, W. M., Thomas, A. M., Ostroumov, A., Dong, Y., & Dani, J. A. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.07.007 · Cited by 77 · see citing works
“Glucocorticoids potently interact with the inflammatory pathways [297-299] and modify the immune responses to nicotine and alcohol [297, 300].”
Shchaslyvyi, A. Y., Antonenko, S. V., & Telegeev, G. D. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21081077 · Cited by 73 · see citing works
From Traumatic Childhood to Cocaine Abuse: The Critical Function of the Immune System
Iacono, L. L., Catale, C., Martini, A., Valzania, A., Viscomi, M. T., Chiurchiù, V., Guatteo, E., Bussone, S., Perrone, F., Sabato, P. D., et al. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.05.022 · Cited by 71 · see citing works
Stress, sensitive periods, and substance abuse
Andersen, S. L. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.100140 · Cited by 92 · see citing works
Jacobsen, J. H. W., Watkins, L. R., & Hutchinson, M. R. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801284-0.00006-3 · Cited by 71 · see citing works
Self-citationMind and body: how the health of the body impacts on neuropsychiatry
Renoir, T., Hasebe, K., & Gray, L. J. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00158 · Cited by 62 · see citing works
“Blockade of glucocorticoid signaling can block stress-induced sensitization of microglial inflammatory responses (Frank et al., 2011), and microglial activation can be primed by in vivo exposure to glucocorticoids (Nair and Bonneau, 2006) or chronic stress (Farooq et al., 2012).”
BackgroundJohnson, J. L., Hutchinson, M. R., Williams, D. B., & Rolan, P. E. (2012) · Cephalalgia · doi:10.1177/0333102412467512 · Cited by 63 · see citing works
Opioid-induced microglia reactivity modulates opioid reward, analgesia, and behavior
Green, J. M., Sundman, M., & Chou, Y. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104544 · Cited by 63 · see citing works
Paris, J. J., Brunton, P. J., Russell, J. A., & Frye, C. A. (2011) · Stress · doi:10.3109/10253890.2011.628719 · Cited by 60 · see citing works
“However, glucocorticoids may also exert divergent effects to acutely enhance pro-inflammatory cytokine action and chronically potentiate the neuroinflammatory response to stressors (reviewed by Frank et al. 2011).”
Immune treatments for alcohol use disorder: A translational framework
Meredith, L. R., Burnette, E. M., Grodin, E. N., Irwin, M. R., & Ray, L. A. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.07.023 · Cited by 60 · see citing works
Golovatscka, V., Ennes, H. S., Mayer, E. A., & Bradesi, S. (2012) · NeuroImmunoModulation · doi:10.1159/000342092 · Cited by 56 · see citing works
Interactions of HIV and Drugs of Abuse
Hauser, K. F., & Knapp, P. E. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801284-0.00009-9 · Cited by 55 · see citing works
Cooper, Z. D., Jones, J. D., & Comer, S. D. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.651123 · Cited by 47 · see citing works
Franklin, K. M., Hauser, S. R., Lasek, A. W., McClintick, J., Ding, Z.-M., McBride, W. J., & Bell, R. L. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3852-3 · Cited by 44 · see citing works
“, hypothalamic-pituitary-adrenal axis), and transcription activity within reward neurocircuitry (Allen et al. 2011; Crews and Nixon 2009; Crews et al. 2011; Frank et al. 2011; Kelley and Dantzer 2011; Misra and Pandey 2006; Rosi 2011; Yakovleva et al. 2011).”
Sun, R., Zhao, Z., Feng, J., Bo, J., Rong, H., Lei, Y., Lu, C., Zhang, X., Hou, B., Sun, Y., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9976-1 · Cited by 45 · see citing works
“microglial activation state by stress was reported to be associated with elevated glucocorticoids (GCs) [28, 32, 33] caused by alterations in hypothalamic-pituitary-adrenal (HPA) axis”
BackgroundKarelina, K., Nicholson, S., & Weil, Z. M. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.01.012 · Cited by 44 · see citing works
Bell, I. R., Koithan, M. S., & Brooks, A. J. (2013) · Homeopathy · doi:10.1016/j.homp.2012.10.005 · Cited by 44 · see citing works
Microglia in neuroimmunopharmacology and drug addiction
Li, H., Watkins, L. R., & Wang, X. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02443-6 · Cited by 41 · see citing works
“Microglia and opioid addiction Similar to psychostimulant addiction, emerging evidences show that opioid-induced morphological and molecular activation in response to opioids is related to the development and maintenance of opioid reward, tolerance, dependence, and withdrawal [96 – 99].”
Self-citationZhang, H., Wang, J., Ruan, C., Gao, Z., Zhu, Q., & Li, S. (2022) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2022.129093 · Cited by 38 · see citing works
Ashley, N. T., Sams, D. W., Brown, A. C., & Dumaine, J. E. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.01.013 · Cited by 38 · see citing works
Aguirre, A., Maturana, C. J., Harcha, P. A., & Sáez, J. C. (2013) · Mediators of Inflammation · doi:10.1155/2013/893521 · Cited by 37 · see citing works
“An interesting aspect is that drugs of abuse may directly activate microglial and astroglial cells via TLRs, which mediate the innate immune response to pathogens [216].”
BackgroundCippitelli, A., Damadzic, R., Hamelink, C., Brunnquell, M., Thorsell, A., Heilig, M. A., & Eskay, R. L. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2012.00451.x · Cited by 37 · see citing works
SCI and depression: Does inflammation commandeer the brain?
Brakel, K., & Hook, M. A. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.112977 · Cited by 34 · see citing works
Cannabidiol Analogue CIAC001 for the Treatment of Morphine-Induced Addiction by Targeting PKM2
Jin, S., Lin, C., Wang, Y., Wang, H., Wen, X., Xiao, P., Li, X., Peng, Y., Sun, J., Lu, Y., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01029 · Cited by 31 · see citing works
Sun, R., Liu, Y., Hou, B., Lei, Y., Bo, J., Zhang, W., Sun, Y., Zhang, Y., Zhang, Z., Liu, Z., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.02.017 · Cited by 31 · see citing works
Early life stress increases vulnerability to the sequelae of pediatric mild traumatic brain injury
Díaz-Chávez, A., Lajud, N., Roque, A., B, J. P. C. A., Meléndez‐Herrera, E., Valdez-Alarcón, J. J., Bondi, C. O., & Kline, A. E. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113318 · Cited by 31 · see citing works
“, 2013) and are highly responsive cells that react to stress (Frank et al., 2011), making them suitable candidates to mediate the effects of stress exposure and pediatric mTBI.”
BackgroundWijenayake, S., Rahman, M. F., Lum, C. M. W., de Vega, W. C., Sasaki, A., & McGowan, P. O. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01798-1 · Cited by 24 · see citing works
Sanders, A. F. P., Tirado, B. A., Seider, N. A., Triplett, R. L., Lean, R. E., Neil, J. J., Miller, J. P., Tillman, R., Smyser, T. A., Barch, D. M., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02782-6 · Cited by 27 · see citing works
Grodin, E. N., Nieto, S. J., Meredith, L. R., Burnette, E., O'Neill, J., Alger, J., London, E. D., Miotto, K., Evans, C. J., Irwin, M. R., et al. (2022) · Addiction Biology · doi:10.1111/adb.13182 · Cited by 25 · see citing works
Feltes, P. K., de Vries, E. F. J., Juárez‐Orozco, L. E., Kurtys, E., Dierckx, R., Jeckel, C. M. M., & Doorduin, J. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17747189 · Cited by 24 · see citing works
Ma, J., Chen, Y., Wang, Z., Wang, R., & Dong, Y. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105710 · Cited by 24 · see citing works
Doremus‐Fitzwater, T. L., Paniccia, J. E., Gano, A., Vore, A. S., & Deak, T. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.02.009 · Cited by 23 · see citing works
Smiley, C. E., & Wood, S. K. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108212 · Cited by 23 · see citing works
Avalos, M. P., Guzman, A. S., Rigoni, D., Gorostiza, E. A., Sanchez, M. A., Mongi‐Bragato, B., García‐Keller, C., Perassi, E. M., Virgolini, M. B., Ramos, J. M. P., et al. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.01.014 · Cited by 20 · see citing works
Neuroimmune mechanisms of brain function and alcohol related disorders
Cui, C., Grandison, L., & Noronha, A. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.03.005 · Cited by 19 · see citing works
“Frank et al. (2011) review the potential mechanism underlying stress-induced vulnerability to drugs of abuse.”
BackgroundLovelock, D. F., Randall, P. A., Voorhies, K. J. V., Vetreno, R. P., Crews, F. T., & Besheer, J. (2021) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173379 · Cited by 18 · see citing works
Sexual attraction and the nonmedical use of opioids and sedative drugs among Chinese adolescents
Li, P., Huang, Y., Guo, L., Wang, W., Xi, C., Lei, Y., Luo, M., Pan, S., Deng, X., Zhang, W., et al. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.10.038 · Cited by 18 · see citing works
Early Life Stress, Neuroinflammation, and Psychiatric Illness of Adulthood
Shin, S. H., & Kim, Y. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_6 · Cited by 18 · see citing works
Lutgendorf, S. K., Zia, S., Luo, Y., O’Donnell, M. A., van Bokhoven, A., Bradley, C. S., Gallup, R., Pierce, J. M., Taple, B. J., Naliboff, B. D., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.03.024 · Cited by 19 · see citing works
Tarai, S., Mukherjee, R., Gupta, S., Rizvanov, A. A., Palotás, A., Pammi, V. S. C., & Bit, A. (2019) · Cognitive Neurodynamics · doi:10.1007/s11571-019-09522-3 · Cited by 16 · see citing works
Kamimura, Y., Kuwagaki, E., Hamano, S., Kobayashi, M., Yamada, Y., Takahata, Y., Yoshimoto, W., Morimoto, H., Yasukawa, T., Uozumi, Y., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119821 · Cited by 16 · see citing works
Im, S., Choi, H. S., Choi, S. O., Kim, K., Lee, S., Hwang, B. Y., Lee, M. K., & Lee, C. K. (2012) · Molecules · doi:10.3390/molecules17077695 · Cited by 15 · see citing works
“In mammals, the integrated response to stress includes a number of neuroendocrine molecules of both the hypothalamic-pituitaryadrenal axis and the sympathetic nervous system, such as catecholamines, adrenocorticotropin and glucocorticoids [19–21].”
BackgroundAnhedonia in cocaine use disorder is associated with inflammatory gene expression
Fries, G. R., Khan, S. H., Stamatovich, S. N., Dyukova, E., Walss‐Bass, C., Lane, S. D., Schmitz, J. M., & Wardle, M. C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207231 · Cited by 14 · see citing works
Investigational drugs for alcohol use disorders: a review of preclinical data
Ch’ng, S. S., & Lawrence, A. J. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1472763 · Cited by 14 · see citing works
“Indeed, modulation of neuroimmune signaling via microglial cells and astrocytes promotes stress-induced drug seeking [98].”
BackgroundEnayatfard, L., Rostami, F., Nasoohi, S., Oryan, S., Ahmadiani, A., & Dargahi, L. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8238-x · Cited by 14 · see citing works
“Although the mechanisms underlying the B.S. in chronic drug use is not well described yet, growing evidence implies the role of neuroinflammatory mediators in the development of drug addiction as well as many other neurological and psychiatric diseases (Frank et al. 2011).”
BackgroundWang, Y., Cao, X., Ma, H., Tan, W., Zhang, L., Li, Z., & Gao, Y. (2016) · Brain Research · doi:10.1016/j.brainres.2016.07.045 · Cited by 13 · see citing works
“CD200 binding its receptor CD200R is thought to constitutively maintain glial cell in a quiescent state (Frank et al., 2011; Yi et al., 2012).”
Anti-Inflammatory Therapy as a Promising Target in Neuropsychiatric Disorders
Ballaz, S., & Bourin, M. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_20 · Cited by 9 · see citing works
Is the Neuroimmune System a Therapeutic Target for Opioid Use Disorder? A Systematic Review
Toloff, K., & Woodcock, E. A. (2022) · Medical Research Archives · doi:10.18103/mra.v10i8.2955 · Cited by 8 · see citing works
The relationship between fear extinction and resilience to drug-dependence in rats
Ueno, M., Yamada, K., & Ichitani, Y. (2017) · Neuroscience Research · doi:10.1016/j.neures.2017.03.006 · Cited by 8 · see citing works
Everson, C. A., Szabó, A., Olsen, C. M., Glaeser, B., & Raff, H. (2025) · SLEEP · doi:10.1093/sleep/zsaf107 · Cited by 7 · see citing works
Systemic inflammation enhances stimulant-induced striatal dopamine elevation in tobacco smokers
Zakiniaeiz, Y., Hoye, J., Petrulli, J. R., LeVasseur, B., Stanley, G., Gao, H., Najafzadeh, S., Ropchan, J. R., Nabulsi, N., Huang, Y. H., et al. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.08.016 · Cited by 7 · see citing works
“Studies have demonstrated that drugs and alcohol interact with the neuroimmune system and alter neuroimmune gene expression and signaling (Frank et al., 2011; Haroon et al., 2012), which in turn contribute to various reinforcing and addictive properties of addiction including reward, stress,…”
Cancela, L. M., Mongi‐Bragato, B., Avalos, M. P., & Bollati, F. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010385 · Cited by 9 · see citing works
“In this context, stress and glucocorticoids have been shown to sensitize neuroinflammatory responses to subsequent drug exposure, indicating that immune mechanisms may play a crucial role in mediating stress-induced vulnerability to addiction [231,272,273].”
Saidian, K., Sohrabi, A., & Zemestani, M. (2019) · journal of ilam university of medical sciences · doi:10.29252/sjimu.27.1.161 · Cited by 6 · see citing works
Kong, W., Jiang, P., Miao, X., Sang, B., Hu, S., & Feng, L. (2025) · Cell Stress and Chaperones · doi:10.1016/j.cstres.2025.100112 · Cited by 5 · see citing works
Li, L., Zhu, H., Qi, Y. A. N., Li, S.-Y., & Li, F. (2020) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(20)30042-x · Cited by 5 · see citing works
Bell, I. R. (2012) · Cited by 5 · see citing works
Microglial phagocytosis and regulatory mechanisms: Key players in the pathophysiology of depression
Wang, M., Jin, G., Duan, T., Li, R., Gao, Y., Yu, M., & Xu, Y. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110383 · Cited by 6 · see citing works
Jiang, M., Huang, Y., Hu, L., Wu, H., Liu, Y., Ni, K., Zhang, X.-K., Sun, Y., & Gu, X. (2022) · Molecular Pain · doi:10.1177/17448069221099360 · Cited by 4 · see citing works
“Activation of microglia to a pro-inflammatory immunophenotype can be facilitated by exposure to some stressors.(27) Microglia activation and neuro-inflammatory responses to LPS were found to increase in rats exposed to chronic variable stress.”
BackgroundMerritt, K., Palmer, E. R., Laguna, P. A. L., Sethi, A., Rogers, J. C., Evans, C. J., Reichenberg, A., Khandaker, G. M., Upthegrove, R., Lewis, G., et al. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106247 · Cited by 3 · see citing works
“Early developmental insults such as childhood inflammation may have a priming effect on microglia in the brain, which may increase microglial activation and psychosis risk following subsequent infections (Frank et al., 2007; Frank et al., 2011).”
Raise‐Abdullahi, P., Rahmani, M., Tabaei, N. S., Rezamohammadi, F., Vafaei, A. A., Ghanbari, A., Rashidipour, H., Meamar, M., & Rashidy‐Pour, A. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.01.012 · Cited by 3 · see citing works
Sabbag, T., Kritman, M., & Akirav, I. (2025) · Cells · doi:10.3390/cells14120938 · Cited by 3 · see citing works
“Interestingly, chronic stress may suppress neuroinflammation in specific brain regions by reducing neuronal activity, impairing astrocytic signaling, or decreasing microglial activation [82,83].”
Koob, G. F., Arends, M. A., McCracken, M. L., & Moal, M. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816990-2.00001-6 · Cited by 4 · see citing works
How omics is revealing new roles for glia in addiction
Bergkamp, D. J., & Neumaier, J. F. (2024) · Glia · doi:10.1002/glia.24584 · Cited by 3 · see citing works
“Many cytokines may play a role in the biology of addiction (Frank et al., 2011), including those released by microglia (Schwarz & Bilbo, 2013), as a response to neuronal activity changes induced during withdrawal (Parekh et al., 2021).”
Chang, S. L., & Liu, X. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4729-0_15 · Cited by 3 · see citing works
Shah, L., Yoon, C. D., LaJeunesse, A. M., Schirmer, L. G., Rapallini, E. W., Planalp, E. M., & Dean, D. (2025) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2025.1613084 · Cited by 5 · see citing works
Conclusions: Therapeutic Potential of Novel Cannabinoid Receptors
Abood, M. E., Sorensen, R. G., & Stella, N. (2012) · The Receptors · doi:10.1007/978-1-4614-4669-9_12 · Cited by 2 · see citing works
Stress and drug addiction: an up-to-date perspective from 2020
Wojdała, A. L., Molins, F., & Serrano, M. Á. (2020) · Adicciones · doi:10.20882/adicciones.1470 · Cited by 2 · see citing works
Dodick, D. W., & Silberstein, S. D. (2016) · doi:10.1093/med/9780199793617.003.0005 · Cited by 2 · see citing works
Zhang, B., Zhang, J., Zhu, M., Fan, Y., & Xue, Y. (2025) · Addiction Biology · doi:10.1111/adb.70103 · Cited by 1 · see citing works
“This inflammatory milieu, involving microglial activation, astrocytic dysfunction and peripheral immune cell infiltration [6], disrupts synaptic homeostasis, impairs neuro-plasticity and contributes to the characteristic cognitive and emotional deficits of AUD [7].”
Neuroprotective Effects of Carnosine Against Corticosterone‐Induced Depression and Memory Impairment
Elahi, M., Samad, N., Irfan, A., Manzoor, N., Ahmed, M. Z., Матеев, Е., & Jardan, Y. A. B. (2026) · Food Science & Nutrition · doi:10.1002/fsn3.71837 · Cited by 1 · see citing works
“…Shaw et al. 2024), the induction of neuroinflammatory processes through microglial priming and increased production of pro-inflammatory cytokines (Frank et al. 2011; Munhoz et al. 2006), and the disruption of neurotransmitter systems such as glutamatergic, GABAergic, and monoaminergic…”
STRESS AND INFLAMMATION: A DETRIMENTAL COMBINATION IN THE DEVELOPMENT OF NEURODEGENERATIVE DISEASE.
de Pablos, R. M., Espinosa‐Oliva, A. M., Soto, M. S., & Venero, J. L. (2014) · Inflammation and Cell Signaling · doi:10.14800/ics.182 · Cited by 1 · see citing works
“When primingoccurs in microglia or peripheral macrophages, these sensitized cells do not produce inflammatory or anti-inflammatory products, but if further stimulated they turn into a high inflammatory profile ([71-77]).”
BackgroundEtiopathogenesis of medication abuse headache (MOH): abuse of analgesics
Martínez, M. D. V. L., Román, J. P., Hernández, M. D. J., Unturbe, C. M., & Ramirez–Castillejo, M. D. C. (2019) · Journal of Applied Biotechnology & Bioengineering · doi:10.15406/jabb.2019.06.00206 · Cited by 1 · see citing works
Yampolskaya, S., Walker-Egea, C., Callejas, L. M., & Jarvis, J. E. (2025) · Journal of Social Service Research · doi:10.1080/01488376.2025.2451937 · Cited by 1 · see citing works
“A review of studies focusing on stress and drug misuse concluded that stressors exacerbate a variety of drug-related behaviors (Frank et al., 2011).”
- Authors
- Frank, M. G., Watkins, L. R., & Maier, S. F.
- Affiliations
- University of Colorado Boulder (US)
- Corresponding author
- Frank, Matthew G.
- Venue
- Brain, Behavior, and Immunity
- Publisher
- Elsevier BV
- Published
- 2011-06
- Volume
- 25
- Pages
- S21-S28
- ISSN
- 0889-1591 (ISSN-L)
- PMC
- PMC5654377
- OpenAlex
- W2016770411
- Semantic Scholar
- f1b101753dbcbe06813ae6ae78eb3e594eeaaf5e
- Cited by
- 116
- References
- 120
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 5 · 2023: 6 · 2022: 9 · 2021: 9 · 2020: 5 · 2019: 8 · 2018: 8 · 2017: 5 · 2016: 7 · 2015: 7 · 2014: 11 · 2013: 8 · 2012: 12
- FWCI
- 1.02
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Brain Behavior and Immunity (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (R21MH096224)
- National Institute of Dental and Craniofacial Research (R01DE021966)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- stress, glucocorticoids, neuroinflammation, drug abuse, drug addiction, microglia, astrocytes, inflammatory cytokines, IL-1β, Toll-like receptors, neuroimmune interactions, substance dependence, drug reward, opioids, psychostimulants, alcohol
- MeSH terms
- Animals, Disease Susceptibility, Encephalitis, Glucocorticoids, Immunity, Innate, Stress, Physiological, Stress, Psychological, Neuroimmunomodulation, Substance-Related Disorders, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review